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Research on plant diseases has been carried out for decades all over the world. In order 
to ensure good yields and farmers’ profits, farmers and scientists try their best to control 
plant diseases which cause yield losses. Plant viruses are among the most significant 
pathogens that threaten plant growth and production. For instance, Cotton leaf curl virus 
(genus: Begomovirus) caused a loss estimated at 5 billion US$ in Pakistan between 
1992 to 1997 (Briddon & Markham, 2000). Sweetpotato chlorotic stunt virus (genus 
Crinivirus) reduces yields by approximately 30 to 80% in sweatpotato (Gibson & 
Aritua, 2002). Tomato yellow leaf curl virus (genus: Begomovirus) causes diseases in 
tomatoes in USA, Greece, Morocco and other countries; and in many tropical and 
subtropical regions, the losses are up to 100% (Agrama & Scott, 2006). 
Viruses which exist in non-cultivated plant communities are generally considered 
not to be harmful, however, the relationships between viruses infecting wild plants and 
cultivated crops may be underestimated. Wild plants may be a source of agriculture-
related viral pathogens. Viruses are transmitted by aphids and other vector organisms, 
which can bring viruses to around fields, and pose threats to agricultural production. 
Furthermore, in wild plants, viruses retain large biodiversities and abundance, which 
suggests their importance in ecosystems. 
1.1 Plant viruses 
The earliest written record about an almost certain plant viral disease was mentioned in 
a Japanese poem in 752 AD. Paintings and drawings in 17th century from the 
Netherlands demonstrated flower viral disease symptoms in tulips, known as the leading 
“tulipomania” (Hull, 2002). In 1898, Martinus Willem Beijerinck separated a non-
bacteria infective agent, which was considered as the birth of virology (Zaitlin, 1998; 
Bos, 1995). In 1955, Fraenkel-Conrat and Williams isolated naked RNA and protective 
coat protein of Tobacco mosaic virus (TMV) (Fraenkel-Conrat & Williams, 1955). 
Then they demonstrated that only the RNA molecule is sufficient for viral infectivity, 
and RNA carries information for coat protein synthesis (Fraenkel-Conrat, 1956). The 
discovery initiated modern virology. Till 2009, 2284 species of viruses have been 
discovered (ICTV: http://ictvonline.org/virusTaxInfo.asp),  and almost half  of them can 




With the development of virology, taxonomy of viruses has changed. Till 2009, 87 
viral  families  were  classified  by  ICTV  (http://www.ictvonline.org/virusTaxonomy. 
asp?version=2009),  and  viruses  from  at  least  31  families  can  infect  plants  
(http://www.dpvweb.net/notes/families.php). The criteria used in viral classification 
include seven characteristics: a) structure of the viral particle; b) physicochemical 
properties of viral particle; c) properties of viral nucleic acids; d) viral proteins; e) 
serological relationships; f) activities in the plant and g) means of transmission (Hull, 
2002).   
The  typical  plant  viruses  consist  of  a  genomic  nucleic  acid  protected  by  a  protein  
coat. The genome can consist of one or more nucleic acids, which could be either DNA 
or RNA, and could be either single-stranded or double-stranded. Plant viral genome(s) 
encode 1 to 12 proteins, which have functions in replication, movement, transmission, 
structure and infectivity (Hull, 2002). Viruses are obligate parasites, which means that 
they cannot survive independently out of a living host. The multiplication of plant 
viruses consist of five main steps. 1) The virus enters the host cell. Most plant viruses 
enter the host through wounds, or are transmitted by vectors that feed on the plant. 2) 
Uncoating and release of the viral genomic nucleic acid. 3) Replication of viral genome 
and synthesis of viral protein. 4) Self-assembly of viral particles and 5) spread of 
viruses to neighbouring cells through plasmodesmata, and transport to other parts of the 
host through vascular tissues. 
1.1.1 Viral genomes and replication 
Viruses with different nucleic acid types differ in the viral genome replication process. 
Most plant viruses have a positive single-stranded RNA (+ssRNA) genome. After 
protein  uncoating,  the  viral  RNA  is  utilized  as  template,  for  synthesis  of  a  
complementary  RNA strand  by  the  viral  RNA polymerase.  The  complementary  RNA,  
which is in negative sense, is dissociated from the original positive RNA, and serves as 
the template for viral RNA synthesis (Figure 1). Some viruses with negative single-
stranded RNA (-ssRNA) have to be first transcribed into positive-strand RNA by virus-
carried  transcriptase,  and  then  replicate  as  described  above.  For  some  of  the  plant  
viruses with double-stranded RNA (dsRNA), genome replication occurs in a subviral 
particle, which is called core. Core includes the viral genome and RNA dependent RNA 




of RdRp, and then the positive-strand RNA is exported to cytoplasm where it acts 
similar  to  mRNA.  The  viral  mRNA  is  translated  to  a  protein  and  assembles  with  the  
new synthesized proteins to become an immature virion. Inside this virion, mRNA is 
transcribed to produce a negative-strand, and a new virion is formed (Ball, 2007).  
 
Figure 1. Schematic representation of +ssRNA viral replication. 
 
Some plant viruses have single-stranded DNA (ssDNA); the replication mechanism of 
these  viruses  relies  on  using  cellular  DNA  replication  proteins.  ssDNA  first  has  to  be  
converted into double-stranded DNA, and forming a circle and producing a negative-
strand used as template to multiple positive-strands which are cleaved to the genome 
unit (Gutierrez, 1999) (Figure 2).  
 





For a few viruses with double-stranded DNA (dsDNA), the viral genome enters host 
nucleus and forms a mini-chromosome by twisting and supercoiling. The mini-
chromosome is transcribed into two ssRNA: the smaller one is used for protein 
translation, and the bigger one is encapsulated by coat protein and is served as the 
template for reverse transcription to produce a dsDNA virus (Agrios, 2005).    
1.1.2 Virus movement 
Viruses  complete  the  replication  process  in  the  initially  infected  host  cell,  and  then  
spread to other cells. Viral movement between host cells relies on specific movement 
proteins. Viral movement is divided to two phases: cell-to-cell movement and long 
distance transportation. Cell-to-cell movement is operated by movement protein(s) 
(MP).  There  are  a  range  of  types  of  MP encoded  by  the  viral  genome.  To  complete  a  
movement, one or several MPs are required to mediate intracellular movement and 
intercellular viral spread via plasmodesmata depending on virus species (Lucas, 2006).  
By cell-to-cell movement, viruses spread to the vascular tissue in which they are 
carried together with photosynthates, and move rapidly through the host plant 
systemically.  Viral  long  distance  transport  in  vascular  tissue  mostly  takes  place  in  the  
sieve  tube  system  of  phloem  (Gilbertson  &  Lucas,  1996).  Some  beetle-transmitted  
viruses can be transported through xylem (Fulton et al., 1987). Viruses require several 
days to spread toward growing regions or other energy-utilizing parts since the infection 
started (Figure 3).  
 






1.1.3 Virus transmission 
Viruses have no movable reproductive structure, such as spores in fungi. Therefore viral 
transmission between host plants depends on contact between an infected plant and a 
healthy plant, or transmission by vectors. Contact infection includes vegetative 
propagation and mechanical transmission in sap, which is commonly used for 
experimental inoculation in laboratory. The other way for viral transmission between 
host individuals is with the help of other organisms, called vectors. Viral vectors include 
insects, mites, nematodes and fungus-like organisms. Usually, a vector has an ability to 
transmit only a few types of viruses, and a virus can be transmitted by only a few kinds 
of vectors. Some viruses exist in plant pollen and seeds, and appear in the next 
generation of plant. The mechanisms of these cross-generation transmissions are called 
pollen-borne and seed-borne transmission, respectively. 
The aforementioned examples reveal that the mechanisms of viral infection and 
viral diseases in plants are different from diseases caused by other pathogens. Bacteria 
or fungal pathogens cause diseases by producing enzymes, toxins or other pathogenic 
substances which have negative effects on the host, or consume nutrients of the host 
cells as parasites. By contrast, viruses affect plants in an indirect way. For instance, 
viruses cause symptoms such as leaf mosaic, ring spots, dwarfing, or stunting by 
interfering with the normal host metabolism. Many viruses cause visible symptoms in 
the infected plant, however, some infected plants are symptomless. Viruses in 
symptomless plants are called latent viruses.  
1.2 Virus detection 
Several methods have been developed to detect plant viruses, such as the enzyme-linked 
immunosorbent assay (ELISA), polymerase chain reaction (PCR), molecular beacons, 
immune-capillary zone electrophoresis (I-CZE), liquid chromatography, nucleic acid 
sequence based amplification (NASBA) (Wong, 2002) and loop-mediated isothermal 
amplification (LAMP) (Notomi et al., 2000).   
ELISA is a biochemical tool used mainly in medical immunology and plant 
pathology for pathogen diagnostics (Clark & Adams, 1977). It is performed in an 




immobilized antibodies, which can bind antigens from plant sample. Combined antigens 
capture the second specific antibodies, which can be detected by florescent techniques. 
ELISA test is rapid and sensitive, thus viruses in low titres may be detected (Stynen et 
al., 1995).  
PCR has been used in plant virus detection since early 1990s (Wong, 2002). For 
RNA viruses, viral RNA has to be reverse transcribed to complementary DNA (cDNA) 
which  is  used  as  template  for  PCR.  PCR  techniques,  such  as  multiplex  PCR,  allow  
simultaneous detection of several viruses (Mumford et al., 2000); and real-time PCR 
enables quantification, which can be used to determine viral concentration.  
Molecular beacons are used to detect target sequence by a single-stranded nucleic 
acid probe which contains a hairpin structure. The probe sequence, which is 
complementary to the target nucleic acid, locates in the loop portion of hairpin structure. 
The two arm sequences are unrelated to the target sequence, and are complementary 
with each other to form the stem of hairpin. A fluorescent moiety is attached to the end 
of one arm of the hairpin structure, and a fluorescent quencher moiety is attached to the 
other arm. The two moieties are at a close proximity due to the two complementary 
arms of the stem. When the probe at the loop hybridizes to a target sequence, the hairpin 
structure is destructed and the two arms are separated. The separation leads to the 
detachment of the two moieties, and appearance of fluorescence (Tyagi & Kramer, 
1996). Eun and Wong successfully detected Cymbidium mosaic virus (CymMV: genus 
Potexvirus) and Odontoglossum ringspot virus (ORSV: genus Tobamovirus) by 
molecular beacons (Eun & Wong, 2000).  
I-CZE was also used by Eun and Wong (1999) to detect the above-mentioned two 
viruses. I-CZE combines the specificity afforded by serological assays with CZE. Based 
on the principle of CZE which separates components in samples by applying a voltage 
across a hollow capillary filled with electrolyte solution, I-CZE migrates antigen-
antibody complexes, and the migration of complexes can be detected in real time.  
Liquid chromatography is used in protein chemistry in conjunction with 
electrospray ionization (ESI) and matrix-assisted laser desorption/ ionization (MALDI) 
techniques. The method was proposed for identification of mutants of Tobacco mosaic 
virus (TMV: genus Tobamovirus) (Lewis et al., 1998). All viruses with known coat 
protein molecular weights can be detected by this rapid, accurate and sensitive 





NASBA is an isothermal amplification method for amplifying RNA. The technique 
integrates reverse transcription into the amplification process, and produces single 
stranded RNA. Potato leafroll virus (PLRV: genus Polerovirus) in potato tubers was 
detected by this method (Leone et al., 1997).  
LAMP was developed by Notomi et al. (2000)  to  amplify  DNA  at  a  constant  
temperature (60 °C). On the target DNA, four specific primers recognize six distinct 
sequences. A complementary strand is synthesised by inner primer, after which the out 
primer releases the single-stranded DNA which serves as a template for the next cycle 
of  DNA  synthesis.  The  new  strand  hybridizes  to  the  target  DNA,  and  a  stem-loop  
structure is produced by the hybridization. As the reaction continues, more stem-loop 
structures and DNA strands are produced (Notomi et al., 2000). Because of the high 
selectivity and relatively more rapid reaction process of the LAMP method, it is widely 
used for DNA amplifications (Fukuta et al., 2003, Fukuta et al., 2004, Nie, 2005).  
However, all techniques mentioned above rely on some presumption of the virus in 
order to design the primers or probes. Therefore most of them suit to detect viruses in 
cultivated plants. For wild plants which grow outside fields and gardens, there is little 
information about viral diseases, and it is difficult to suspect specific viral pathogens. 
Recently, a novel method was developed to provide an effective solution to detect 
viruses from plants without previous study. The method assembles viral small RNA 
reads from infected plants to contigs, and the contigs are used to search hits with Basic 
local alignment search tool (BLAST) in the nucleotide and protein databases of the 
National Center for Biotechnology Information (NCBI). In the study conducted by 
Kreuze et al. (2009), sweetpotato was infected by Sweetpotato feathery mottle virus 
(SPFMV: genus Potyvirus) and Sweetpotato chlorotic stunt virus (SPCSV:  genus  
Crinivirus). Surprisingly, besides SPFMV and SPCSV RNAs, mastrevirus- and 
badnavirus-specific RNAs were also detected (Kreuze et al., 2009).  The outcomes 
indicated that there exist more kinds of viruses than expected, even in crops which are 
well studied. The small RNA deep-sequencing method makes it possible to detect 
viruses without any prior knowledge, and it can be used for discovering viruses from the 




1.3 RNA silencing   
1.3.1 Gene silencing 
Gene silencing is generally described as suppression of gene activity at the mRNA 
expression level. It includes two types of mechanisms: transcriptional gene silencing 
(TGS) and posttranscriptional gene silencing (PTGS), or RNA silencing. RNA silencing 
refers to the process of down-regulation of gene expression triggered by dsRNA. The 
mechanism was first mentioned by Napoli et al. (1990) when they tried to overexpress 
chalcone synthase in colourful Petunia petals. However, they unexpectedly got 
variegated white flower instead of a dark-purple one in transgenic Petunia, because 
RNA silencing was induced and reduced mRNA accumulation. There are three types of 
RNA silencing in plants: cytoplasmic RNA silencing pathway, endogenous mRNA 
silencing pathway and DNA methylation and suppression of transcription (Baulcombe, 
2004). In a virus-infected plant, cytoplasmic RNA silencing pathway provides an 
efficient virus resistance mechanism. 
1.3.2 Virus-induced RNA silencing in plants  
Virus-induced RNA silencing occurs in three main steps: initiation, amplification and 
spreading. The initiation is triggered by dsRNA, which is derived from replicating viral 
dsRNA or stem-loop structures in viral ssRNA, or it may be synthesized by one or more 
cellular RNA-dependent RNA polymerases (RdRp) that use viral ssRNA as a template. 
The dsRNA is recognized and accurately cleaved into viral small interfering RNAs 
(vsiRNAs) by Dicer-like (DCL) endonucleases (Voinnet, 2008). Unlike animals and 
fungi which possess one or two DCL genes, there are four DCL genes  reported  from  
rice and Arabidopsis thaliana (Margis et al., 2006). The Dicers hierarchically process 
dsRNA  into  vsiRNAs  of  different  sizes,  which  direct  a  series  of  gene-silencing  
pathways (Fusaro et al., 2006). DCL4 is the primary sensor of viral dsRNA, and it 
produces 21 nt long vsiRNAs which are RNA components of the cell-to-cell silencing 
signals in plants (Dunoyer et al., 2005). DCL2 acts as surrogate of DCL3 or DCL4, and 
produces 22 nt long vsiRNAs (Xie et al., 2004). DCL3 generates 24 nt vsiRNAs in 
nucleus (Matzke & Birchler, 2005). DCL1, the minor contributor, accesses viral dsRNA 




& Watanabe, 2004).  
vsiRNA are stabilized by methylation at their 3’-terminal nucleotide by a 
methyltransferase HEN1 (Chen, 2005). The methylated siRNAs are associated with 
different  ARGONAUTEs  (AGOs)  according  to  the  5’  terminal  nucleotide  of  siRNA,  
and form RNA-induced silencing complexes (RISCs) (Mi et al., 2008). The passenger 
strand, which is one of the vsiRNA strands, is degraded by small RNA degrading 
nucleases. The other strand called guide strand utilizes a sequence homology-dependent 
mechanism to guide RISC to attach to the target ssRNA by sequence-specific 
recognition. RISC serves as a slicer to cleave the target ssRNA (Hutvagner & Simard, 
2008). Most of the cleaved RNA products are degraded by exoribonucleases, however, 
some RNAs are recruited by RdRp and synthesized new dsRNAs, which are the 
preferential substrates for DCL4, DCL3 and DCL2 to produce secondary vsiRNAs 
(Figure 4). Chen et al. (2010) suggested that secondary vsiRNA biogenesis is triggered 
by 22-nucleotide RNAs (Chen et al., 2010), however, the latest study provides 
inconsistent results indicating that 21-nucleotide long RNAs direct the downstream 
pathway (Wang et al., 2011). The secondary pool of vsiRNA spreads throughout the 
plant and acts as mobile silencing signals between cells to support plant systemic 
resistance of virus (Dunoyer et al., 2010).  
 




1.3.3 Viral counter-defence against silencing 
The plant operates with RNA silencing as an antiviral mechanism; correspondingly, 
viruses generate solutions to overcome host antiviral silencing. There are three groups 
of proteins which help viruses to inhibit host antiviral immunity through a) reducing 
siRNA accumulation, b) blocking the silencing signal transport, and c) interfering the 
systemic signalling of RNA silencing (Li & Ding, 2001). These kinds of proteins 
encoded by virus are called viral suppressors of RNA silencing (VSRs). RNA silencing 
process might be blocked because the upstream reactions are interfered in the infected 
cell. For examples, potyviral helper component-proteinase (HC-Pro) interferes with the 
HEN1-mediated methylation vsiRNAs (Yu et al., 2006); and poleroviral P0 degrades 
AGO which serves as the catalytic component in the mechanism (Baumberger et al., 
2007). Suppression of RNA silencing enhances viral accumulation in the host, and helps 
viruses to counter the antiviral defence.  
1.4 Deep-sequencing of siRNA 
1.4.1 Advantages 
Compared with other virus detection methods, the advantages of virus detection by 
deep-sequencing of siRNA are apparent. First, deep-sequencing of siRNA does not 
require any supposition of the pathogen, thus it provides an excellent solution in 
studying viral species with limited available information. Second, it offers an unbiased 
view to all viral species and is not limited by the predictions, and helps to discover new 
viral pathogens even in well-studied plant species. Furthermore, deep-sequencing of 
siRNA is sensitive enough to detect viruses which only have small population in the 
hosts.  
1.4.2 Applications 
Scientists first started to use siRNA deep-sequencing to detect low-frequency viral 
mutations in Human immunodeficiency virus (HIV)  because  of  the  high  sensitivity  of  
the approach (Wang et al., 2007). Then it was used in studies on drug-resistant viral 
mutations, for instance, the worldwide spread flu pandemic in 2009 (H1N1 influenza 




utilized in plant disease diagnostic was conducted by Kreuze et al. (2009). After that, 
Wu et al. (2010) used a similar technology to detect viruses from invertebrates (fruit 
flies, mosquitoes and nematodes) and discovered five previously undescribed viruses, 
among which four only exhibited low sequence similarities to known viruses (Wu et al., 
2010). These two studies suggested that deep-sequencing of vsiRNA is suitable for viral 
detection in both plants and animals. Then, many studies based on the method were 
done in different countries. Coetzee et al. (2010) identified four known viral pathogens 
including Grapevine virus E that had never been reported in South Africa vineyards, 
and built a viral census of South African vineyards using the deep-sequencing method. 
Besides viruses, viroids are also elicitors and targets of the RNA silencing mechanism, 
and can be detected by this method (Di Serio et al., 2009, Bolduc et al., 2010, Navarro 
et al., 2009, Ling et al., 2011). 
In this study, siRNA deep-sequencing method is used to detect viruses in a wild 
plant, Arctium tomentosum Mill. (family Asteraceae, genus Arctium), showing vein 
yellowing and mosaic symptoms in Helsinki, Finland. Arctium tomentosum, which is 
also called woolly burdock or downy burdock, is a biennial herb that grows frequently 
in southern and central Finland. It has been observed throughout Europe except Portugal, 
Ireland and Albania (Flora Italiana: http://luirig.altervista.org/schedeit/ae/arctium_ 
tomentosum.htm),  and  it  is  quite  common  in  southern  Sweden,  central  and  eastern  
Europe and Russia. It is also has been found in several states of USA and several 
provinces  of  Canada,  and  in  a  small  part  of  northern  China  (Den  Virtuella  Floran:  
http://linnaeus.nrm.se/flora/di/astera/arcti/arcttomv.jpg). The plant is usually found by 
roadsides and fence lines, and on waste ground. A.tomentosum completes its life cycle 
biennially. In the first year, a large fleshy taproot is developed, and heart-shaped leaves 
are usually 45 cm long by 40 cm wide with beneath white and woolly hair, and grow as 
a  rosette.  In  the  second year,  the  plants  grow up  to  2  m high  with  flower  heads  at  the  
ends of branches. The leaves are alternated and smaller in size toward the top of a 
mature plant. The floral clusters consist of purple disk florets with overlapping hooked 
bracts. After flowering, the whole shoots of the plant die, and the flower heads turn 
brown. With bristling hook structure, the seeds are spread by attaching to animal skin or 






The  aim  of  this  study  was  to  detect  viruses  in  the  wild  plant,  Arctium tomentosum, 
displaying viral disease symptoms in Helsinki. 
The study also aimed to find out how prevalent the possibly detected viruses are in 







3 MATERIALS AND METHODS 
3.1 Viruses and plants material 
The plants showing vein yellowing and mosaic symptoms were suspected to be infected 
by  plant  viruses.  At  first,  six  samples  (Pe10-15)  with  symptoms  were  collected  from  
Pihlajamäki  (Helsinki,  Finland)  and  total  RNA  from  the  samples  was  extracted  by  
Trizol  (Appendix  1).  RNA  from  the  six  samples  was  pooled  for  siRNA  deep-
sequencing. The works mentioned above were done by other researchers in KPAT 
group (University of Helsinki, Finland). After siRNA deep-sequencing, the data were 
used in this study. 
After viruses had been identified in the first samples, more samples with similar 
disease  symptoms  were  collected  in  Helsinki  (Figure  5)  to  study  the  distribution  of  
viruses. The collected samples were marked as Pih 1-19 (Pihlajamäki), Vi 1-8 (Viikki), 
Pa 1-4 (Pasila), H 1-8 (Hämeenlinnanväylä) and R 1-8 (Rapakiventie) according to the 
sampling site. Fresh leaves were put into liquid nitrogen immediately after collection 
and stored at -80°C till use. 
 




3.2 Plant species identification 
3.2.1 Host identification based on the matK gene sequence 
“Barcode” is a short piece of DNA from organisms used to distinguish the species from 
others. Barcoding has been used in animal taxonomy since 2003, and was developed to 
be used in plant taxonomy since 2007 (Pennisi, 2007). The maturase K (matK) gene is 
one of the seven leading candidate genes of plant “barcode” (Hollingsworth et al., 
2009). It was used for identifying the plant species inspected for viruses in this study. 
Total  DNA  was  extracted  from  leaves  of  two  plants  using  the  
cetyltrimethylammonium bromide (CTAB) method (Allen et al., 2006) and used in 
polymerase chain reaction (PCR). About 200 mg of plant leaf tissue was ground in 
liquid nitrogen, and transferred into a 2 ml Eppendorf tube. Before the leaf tissue 
powder melted, 1.2 ml of pre-heated extraction buffer (65°C) (Appendix 1) was added 
into the tubes. The tubes were vortexed for 10 seconds to mix thoroughly, and incubated 
at 65°C for 30 min with inversion every 10 min. Samples were centrifuged at 13,500 g 
for 10 min at room temperature. The supernatants were transferred into new 1.5 ml 
Eppendorf tubes that contained 800 µl of phenol (pH 7.5): chloroform: isoamyl alcohol 
(25:24:1). Subsequently, samples were mixed by inverting tubes for 20 min at room 
temperature, and were centrifuged at 13,500 g for 10 min to separate the phases. The 
upper aqueous phase was transferred to a new Eppendorf tube containing 800 µl of cold 
ethanol. DNA was precipitated by mixing the solution and incubating for 10 min at 
room temperature, and collected by centrifuging the mixture at 13,500 g for  10  min.  
Supernatants were removed and DNA pellets were resuspended in 250 µl of Tris- 
ethylenediaminetetraacetic acid (TE) buffer (Appendix 1). Resuspended DNAs were 
treated by incubating with 2.5 µl DNase-free RNase at 37°C for 30 min, and 
precipitated with 600 µl of precooled (-20°C) ethanol with 25 µl of 3 M sodium acetate 
(NaAc) at -20°C for 20 min. Then, samples were centrifuged and supernatants were 
removed as described above. DNA pellets were washed by 500 µl of cold 70% ethanol 
with 10 min centrifugation at 13,500 g.  Ethanol  was  removed  carefully  without  
disturbing the pellets, and the pellets were dried in air by keeping the tubes upside down 
for at  least  one hour.  Finally,  DNA was resuspended in 25 µl of nucleotide-free water 
(Sigma W4502), and stored at -80°C till use. 




TCTTAGTTC-3’) and matK5r (5’- GTTCTAGCACAAGAAAGTCG-3’) from Kew 
Royal Botanic Garden’s DNA Barcoding website (http://www.kew.org/barcoding/ 
protocols.html), were ordered from Oligomer Oy (Helsinki, Finland) for amplifying the 
matK gene. The PCR reaction (25 µl) consisted of 18 µl of nucleotide-free water, 2.5 µl 
of 10x Dynazyme buffer (F511), 0.3 µl of 10 mM dNTPs, 0.7 µl of forward primer, 0.7 
µl of reverse primer, 0.3 µl of DynazymeTM II DNA Polymerase (Finnzymes, Espoo, 
Finland) and 2.5 µl of extracted DNA. The PCR program was 94°C for 3 min, followed 
by 35 cycles of 94°C for 25 seconds, 49.5°C for 25 seconds, 72°C for 75 seconds, and 
final extension at 72°C for 10 min. PCR products were analyzed by agarose gel 
electrophoresis by running the gel at 140 V for 40 min, and visualized under UV light. 
The 1% agarose gel was prepared in 1x Tris-acetate-ethylenediaminetetraacetic acid 
(TAE) buffer. Final concentration of 1 µg/ml ethidium bromide was added when the 
agarose solution had cooled down to 60°C. 
PCR products of the expected size were purified from the agarose gel using 
E.Z.N.A  Gel  Extraction  Spin  Protocol  (E.Z.N.A.  TM  gel  extraction  Kit  D2500-02,  
Omega Bio-Tek, Norcross GA, USA) according to the manufacturer’s instructions. 
Specific DNA bands in the gel were rapidly cut by using a wide, clean and sharp scalpel 
under UV light (UV Hoefer Macrovue transilluminator UV25; American Biosciences, 
Blauvelt, NY, USA). The volume of gel slice was determined by weighing it in a 1.5 ml 
Eppendorf tube. Equal volume of Binding Buffer (XP2) was added into the tube 
containing the gel slice, and the tube was incubated at 60°C for 10 min or until the gel 
slice melted completely, and mixed thoroughly by shaking for 2 min. The DNA/agarose 
solution was transferred into a HiBind DNA Mini Column in a 2 ml tube, and the tube 
was centrifuged at 10,000 g for 1 min at room temperature. The flow-through liquid was 
discarded, and 300 µl of Binding Buffer (XP2) was added into the column. The 2 ml 
tube which comprises the colomn was centrifuged again as described, and flow-through 
liquid was discarded. After that, HiBind DNA Mini Column was washed by 700 µl of 
SPW Washing Buffer by centrifuging at 13,000 g for 1 min. The liquid was discarded 
again, and the empty column was centrifuged at the maximal speed for 2 min to dry the 
column matrix.  Subsequently,  the  HiBind  DNA Mini  Column was  placed  into  a  clean  
1.5 ml Eppendorf tube. About 30 µl of nucleotide-free water was added onto the column 
matrix, and the column was incubated for 2 min at room temperature. DNA was eluted 
by centrifuging at the maximal speed for 1 min.  




spectrophotometer at the wavelength of 260 nm. Samples were sequenced at Haartman 
Institute (Helsinki, Finland) and analysed by Basic Local Alignment Search Tool 
(BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.cgi)  of  the  National  Center  for  
Biotechnology Information (NCBI).  
3.2.2 Identification based on morphological characteristics 
Besides identification of the “barcode” gene, morphological observation and 
identification was also done according to a Swedish Flora (Mossberg & Stenberg, 1997) 
with help of botanist Ilpo Kuokka.   
3.3 RNA extraction  
Single-stranded RNA is easily degraded by ribonucleases (RNase). Therefore, it is 
important to keep plant leaves at -80°C before use. Gloves are required during the 
whole experimental process in order to prevent RNase contamination. 
Total RNA was extracted from A.tomentosum samples for reverse transcription 
polymerase chain reaction (RT-PCR) according to the Trizol protocol. In this protocol, 
plant leaf samples were ground into powder in liquid nitrogen, and about 0.4 g leaf 
powder was quickly transferred into a 1.5 ml Eppendorf tube. Prepared Trizol (1ml for 
each sample) (Appendix 1) was added before leaf powder melted, mixed well by 
vortexing and incubated for 5 min at room temperature. Samples were centrifuged at 
12 000 g for  10  min  at  +4°C,  and  the  supernatants  were  transferred  to  new  1.5  ml  
Eppendorf tubes containing 0.2 ml of chloroform. The samples were mixed well 
vigorously shaking by hand. Mixtures were incubated at room temperature for 5-15 min 
and centrifuged for 15 min at 12 000 g at +4°C. The upper aqueous phase was carefully 
transferred into a new 1.5 ml Eppendorf tube without any contamination from the lower 
phase. The same volume of isopropanol was added and mixed well, followed by 
centrifuging at 12 000 g for 20 min at +4°C. All transfers mentioned above were done in 
a fume hood. After centrifugation, supernatant was removed carefully without loss of 
the RNA pellet.  The pellets were then washed with 1 ml of 75% ethanol,  and samples 
were centrifuged for 15 min to collect the pellets. Tubes with RNA pellets were kept 
upside down on a paper tissue for drying the RNA pellets until they became clear at the 




55-60°C for 10 min to make sure the RNA pellets were dissolved completely. The 
concentration and purity of RNA samples were determined by a spectrophotometer at 
the wavelength of 260 nm and the absorbance ratio at 260 nm/280 nm (A260/280) and 
260nm/230 nm (A260/230). Agarose gel electrophoresis was used to check whether 
RNA was intact. 
3.4 siRNA sequencing  
Small RNA deep-sequencing required 10 µg of total RNA which was sent to Fasteris 
SA (Plan-les-Ouates, Switzerland). The main steps of small RNA sequencing include 
separation of RNA by electrophoresis in an acrylamide gel, isolation of small RNA (less 
than 30 nt) from the gel, and ligation with a single-stranded 3’ adapter and a bar-coded 
5’ adapter. Ligated RNA is reverse-transcribed and amplified by PCR to generate the 
DNA Colony Template Library. After quality control of the DNA Colony Template 
Library,  it  is  purified  and  diluted  to  concentration  of  10  nM.  Then,  Illumina  Genome  
Analyzer was applied for high-throughput DNA sequencing. Data were analyzed by GA 
Pipeline to convert images into sequences.  
3.5 Sequence analysis 
3.5.1 Velvet assembly 
Velvet  (http://www.csc.fi/english/research/sciences/bioscience/programs/velvet/index 
_html) is a program used for producing contiguous sequences (contigs) by assembling 
short RNA reads based on De Bruijn graphs. In the De Bruijn graphs, data elements are 
organized around words of k nucleotides (k-mer). Reads are mapped and go through the 
graph in a determined order from one word to the next (Zerbino & Birney, 2008). Reads 
are hashed according to a predefined k-mer, which represents the numbers of 
nucleotides overlapping between reads. Thus, the procedure with large k-mer brings out 
more specific contigs but decreases the read coverage, while small k-mer produces 
contigs with high coverage but in lower specificity (Zerbino, 2008).  
Velvet carried out error removing, which means that it focuses on analyzing 
topological features of sequences instead of correcting errors made by sequencing 
process or biological reason such as polymorphisms. There are three structural types of 




internal reads; and erroneous connections meaning errors due to cloning or distant 
merging tips. Velvet corrects the three errors mentioned above after graph creation and 
allows simultaneous operations (Zerbino & Birney, 2008). 
There  were  several  parameters  which  had  to  be  determined  before  running  the  
program. Parameter coverage cutoff is used to eliminate reads with low coverage, which 
are supposed to be errors. A large cutoff corrects the output, but with a risk that reads in 
low concentration will be wrongly eliminated.  
There were two steps to construct short reads into contigs by Velvet. The first step 
was to produce a hashtable, and create two new files which were necessary for the 
following step. For instance, command:  
  velveth output_dir k-mer –short read.fastq 
was used for achieving the first stage. Multiple read files could be added into the same 
command by separating them with a space. K-mer must be an odd number inferior reads 
length, and in maximum it could be 31. Experience showed that the best k-mer for these 
data were 15 and 17 (Zerbino, 2008).  
The second step produces contigs by typing command: 
    velvetg output_dir –min_contig_lgth 50 -cov_cutoff 5 –unused_reads yes 
This command is used to output the results with determined minimum contigs length 
and the cutoff value (cutoff = 50 in this study).  Since the concentration of some of the 
virus might be relatively low in the host plant, coverage cutoff was set to 5 to prevent 
loss of small amount of viral reads.  
3.5.2 BLAST 
Contigs assembled by Velvet were used to search similar sequences in databases by 
BLAST. The Organism option of BLAST program was limited to viruses in order to 
prevent mismatches, especially for short contigs. Viral sequences from BLAST results 
were used as references for siRNA reads alignment with MAQ and Novoalign.   
3.5.3 siRNA alignment by MAQ 
MAQ  (http://maq.sourceforge.net/index.shtml) was used to build assemblies by 
mapping shotgun reads to a reference sequences. MAQ searches ungapped match with 




the alignment stage. In order to speed up the alignment, MAQ only aligns reads to 
positions  which  have  two  or  fewer  mismatches  in  the  first  28  bp  (default  parameters)  
(Li et al., 2008).  
Generally, selected viral genomic sequences as references can be divided into two 
groups. The first group contains viruses which have been well-studied, and these viruses 
in certain plant might be expected according to prior experiences and studies. The 
efficient presumption significantly saves time for running the program. However, in 
cases where it is difficult to make valuable assumptions, such as with viruses that have 
been little studied, or a host whose viruses have not been studied, the better method is to 
use all viral genome data available in the database as reference. The latter approach 
definitely increases workload, but provides higher chance to detect out novel viruses. 
MAQ process includes several stages. The first thing is to load reference sequences 
(download from database e.g. NCBI) and siRNA reads into the program, and convert 
them into binary fasta format for alignment. After that, statistics of alignment is 
executed and mapping assemblies are built. Finally, consensus sequences and 
assembling qualities are extracted and displayed (MAQ user’s manual, Release 0.5.0).  
MAQ  offers  an  easy  solution  to  run  the  program  by  using  the  EASYRUN  
command. The command does most of procedures in batch if references are in fasta 
format and reads are in fastq format. Command of easyrun script is: 
    maq.pl easyrun -d outdir ref.fasta reads.fastq 
In this command, “outdir” stands for directory which stores the outputs, while 
“ref.fasta” stands for the sequence used as reference in fasta format. “reads.fastq” is the 
fastq file containing siRNA reads. Output of MAQ indicates numbers of aligned reads 
among the total amount of siRNA reads.  
3.5.4 siRNA alignment by Novoalign 
Novoalign (http://www.novocraft.com/main/index.php)  is  a  program  similar  as  MAQ  
and used to align short reads to reference sequences. The difference between the two 
programs is that Novoalign optimizes the algorithm to produce an alignment score more 
accurately. It alleviates the limitations of MAQ that allows two mismatches per read by 
being able to align reads having as many as eight mismatches.   





    novocraft/novoindex ref-formatting-name  ref.fasta 
was used for formatting reference into fasta file.  
Alignment was conducted by command: 
    novocraft/novoalign -d ref-formatting-name -f reads.fastq -F ILMFQ 
In the procedure, “ref-formatting-name” represents the formatted reference file, 
“reads.fastq” represents siRNA reads files in fastq format that need to be aligned, and 
“ILMFQ” is the fastq file with qualified Illunimar coding.  More options about the 
command  are  available  in  Novoalign  user  guide  (http://www.novocraft.com/wiki/tiki-
index.php). 
3.5.5 Alignment analysis 
Viral sequences aligned by the programs might be non-contiguous. The coverage of 
alignment can be tested through comparison between the recovered sequence and the 
sequence in database. MultAlin (http://multalin.toulouse.inra.fr/multalin/multalin.html) 
and ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) are programs to align 
multiple sequences, and used to analyze coverage quality. 
3.6 Virus detection by RT-PCR 
Viruses detected in the samples by siRNA deep-sequencing were confirmed by other 
assays in the laboratory. The individual samples were tested to discover the incidence 
and geographical distribution of the viruses in A.tomentosum. 
3.6.1 Reverse transcription reaction 
To synthesize cDNA on Alstroemeria virus X (AlsVX, genus Potexvirus, family 
Alphaflexiviridae), poly-T oligonucleotide primer (23 T+N) (Oligomer Oy) was used 
because the virus contains a 3’-terminal poly-A tail. cDNA of Fig mosaic virus-Hel 
(FMV, genus Emaravirus) was synthesized using random hexamer primers (Oligomer 
Oy).  
For the reverse transcription reaction, 5 µl of RNA and 2.5 µl of primers (10 mM) 
were  added  into  a  0.5  ml  PCR tube.  The  tube  was  incubated  at  70°C for  5  minutes  to  
allow primers attach, and was chilled on ice immediately to stop the reaction. After 




The mix contained 9 µl of nuclease-free water, 2 µl of 10 mM deoxyribonucleoside 
triphosphates (dNTPs) (Finnzymes, Espoo, Finland), 1 µl of Moloney murine leukemia 
virus (M-MLV)  reverse  transcriptase  (Promega,  Madison,  WI,  USA),  5  µl  of  5x  M-
MLV reverse transcription buffer and 0.5 µl of ribonuclease inhibitor enzyme 
(Promega, Madison, WI, USA). The RNA and reaction components were mixed well 
and the reaction mixes were incubated at 37°C for 60 minutes for synthesis cDNA. 
After that, cDNA were diluted by 2 times and stored at -20°C till use. 
3.6.2 PCR reaction 
Qualities  of  cDNA  were  tested  by  a  positive  control  PCR,  which  used  the  universal  
primers to amplify matK gene  of  plant  samples.  Primers  for  viral  detection  were  
designed by program Primer3 (http://frodo.wi.mit.edu/primer3/). Primers were designed 
to  amplify  a  fragment  of  the  coat  protein  (CP)  gene  of  AlsVX  (Figure  6)  and  the  
putative nucleocapsid protein (NP) gene of the FMV-Hel (Figure 7). Since the amount 
of PCR products in AlsVX-infected samples were too small to be visualized clearly in 
gel electrophoresis, two pairs of primers were designed for amplifying the CP gene of 
AlsVX by nested PCR. The second round reaction (amplified by inner primers) uses the 
products from the first round reaction (amplified by outer primers) as templates. Nested 
PCR promotes PCR results to achieve very high sensitivity. 
 
Figure 6. Genomic RNA of AlsVX. The five open reading frames (ORF) encode the 
replicase protein (ORF1: nt 98-5038), the triple gene block protein 1 (ORF2: nt 5067-
5771), the triple gene block protein 2 (ORF3: nt 5746-6078), the triple gene block 
protein 3 (ORF4: nt 5903-6202) and the coat protein (ORF5: nt 6240-6932). 
 
The PCR mastermix contained all necessary reagents except template (Tables 1-3) was 
divided into PCR tubes. Mastermix helps to control contaminations during pipetting. 






Figure 7. The four genomic RNAs of FMV each contain a single open reading frame 
(ORF). The ORFs encode the RNA-dependent RNA polymerase (RdRp) (ORF1: nt 40-
6993), the putative glycoprotein precursor (ORF2: nt 53-1978), the putative 
nucleocapsid protein (ORF3: nt 100-1047) and the unknown protein P4 (ORF4: nt 82-
1167).  
 
Table 1. The reaction for the first round of PCR for AlsVX detection. 
PCR mix Numbers of PCR cycles 
Mastermix: 10xDynazyme buffer (F511) 2.5 µl 
                    dNTPs 10 mM 0.3 µl    1x 
 








                    Outer forward primer 10 µM 0.7 µl 
                         (5’CCACCGCCTAACTACGAAAA-3’) 
                    Outer reverse primer 10 µM 0.7 µl 
                         (5’TTTTTTTTTTTTTTTTTTTTTTTN-3’) 






                    H2O  18 µl 
Template: cDNA 2.5 µl 
Total   25 µl    1x 10 min 72°C 







Table 2. The reaction for the second round of PCR for AlsVX detection. 
PCR mix Numbers of PCR cycles 
Mastermix: 10xDynazyme buffer (F511) 2.5 µl 
                    dNTPs 10 mM 0.3 µl    1x 
 








                    Inner forward primer 10 µM 0.7 µl 
                         (5’-GGCGACCAACAACATTCTCT-3’) 
                    Inner reverse primer 10 µM 0.7 µl 
                         (5’-CAAACTGTAGAAAAACACCTCC-3’) 
                    Dynazyme 0.3 µl    1x 10 min 72°C 
                    H2O  18 µl 
Template: PCR product from the first round 2.5 µl 
Total   25 µl    
Expected product size (nt): 1 120 
 
Table 3. The reaction of PCR for the FMV-Hel detection. 
PCR mix  Numbers of PCR cycles 
Mastermix: 10xDynazyme buffer (F511) 2.5 µl 
                    dNTPs 10 mM 0.3 µl    1x 
 








                    Forward primer 10 µM 0.7 µl 
                         (5’-TCAACAAACGACTTCCTCACTG-3’) 
                    Reverse primer 10 µM 0.7 µl 
                         (5’-AGGGTGCTGATCTGTCTGCT -3’) 






                    H2O  18 µl 
Template: cDNA 2.5 µl 
Total   25 µl    1x 10 min 72°C 
Expected product size (nt): 604 
 
3.6.3 DNA sequencing and sequence alignment 
PCR products of several samples collected from different sites were purified by 
E.Z.N.A  Gel  Extraction  Spin  Protocol  and  sent  to  Haartman  Institute  (University  of  







3.7 Phylogenetic analysis 
Phylogenetic analysis was carried out to study the evolutionary relationships among 
FMV-Hel isolates and other viruses in the genus Emaravirus. The phylogenic tree was 
constructed by program MEGA 4. In the program, viral nucleotide sequences were first 
translated into amino acid sequences in order to align the proteins among the viruses. 
The alignment was done by ClustalW. After that, viral sequences retrieved from 
databases were trimmed to the same length with the sequences determined from the 
FMV-Hel in this study. The tree was built under the model Kimura 2-parameter by 






4.1 Plant species 
The sequences of the matK gene amplified from two plants were subjected to BLAST 
search. They showed 98% identity at nucleotide level (nucleotide BLAST) and 96% 
identity in amino acid level (BLASTx) with the matK gene of Arctium lappa (Accession 
NO: HM989769.1). However, morphological characteristics including plant size, the 
leaf shape, the primary root and the densely hairy underside of leaves suggested that the 
plant belonged to Arctium tomentosum (Mossberg & Sterberg, 1997). Until now, no 
matK gene of A.tomentosum has been published. 
4.2 Virus identification based on the contigs 
Program Velvet  produced  a  large  amount  of  contigs  (Table  4).  Many of  them showed 
high  identity  to  sequences  in  databases  when subjected  to  BLAST.  BLAST results  on  
the 15 nt and 17 nt hash-length contigs suggested that the viruses in the samples 
belonged to genus Potexvirus (family Alphaflexiviridae), and to genus Emaravirus 
(Table 5).   
The lengths of specific contigs and the coverage of identity fit to known viruses are 
shown in Table 5. With hash-length 15, most contigs which could be aligned were 
between 100-230 nt, and the shortest and largest ones (47 nt and 227 nt) were aligned to 
European mountain ash ringspot-associated virus (EMARAV)  and  AlsVX,  
respectively. With hash-length 17, longer contigs could be aligned with sequences in 
databases. The largest aligned contig (488 nt) and shortest aligned contig (43 nt) 
matched to Fig mosaic associated virus (FMAV) and AlsVX, respectively.  
 




Contigs Size (nt) Maximum 
size <100 100-299 300-599 600-1000 >1000 
15 nt 1055 951 97 5 2 0 36 642 




Table 5. Assembled contigs and their alignment with sequences retrieved from the NCBI database  by nucleotide BLAST.  
 
 
   Hash-length 17 nt Hash length 15 nt 










AlsVX Alphaflexiviridae Potexvirus Japan 
RP gene 314 271/320 (82%) 227 227/240 (95%) 
RP gene 271 273/287 (95%) 167 151/179 (84%) 
CP gene 108 109/116 (94%) 106 104/111 (94%) 
















488 307/375 (82%) 108 82/92 (85%) 
Canada/ 
Can01 
RdRp gene 51 48/55 (87%) 
(Not determined) 
NMV Alphaflexiviridae Potexvirus 
Netherlands RdRp gene 162 41/44 (93%) 




Emaravirus Germany RdRp gene (Not determined) 47 45/47 (96%) 
a NMV: Narcissus mosaic virus.  





4.3 Virus identification based on the vsiRNA reads 
Both programs, MAQ and Novoalign, gave out similar alignment scores. Novoalign 
performed better than MAQ, meaning that it aligned more reads to the references. 
However, the results of both programs were the same when the suspected viruses were 
sorted by alignment scores (Table 6). According to the output, it is clear that AlsVX had 
the highest alignment score in all reads with different sizes. MAQ recovered 40% of the 
genomic nucleotide sequences of AlsVX by aligning siRNA reads. FMAV and FMV 
showed the next highest fit, which MAQ recovered 18% and 17% of their genomeic 
sequences by siRNA alignment, respectively. Generally, reads could be aligned with 10 
viruses, which included AlsVX, FMAV, FMV, Asparagus virus 3 (AV3), Lettuce virus 
X (LeVX), Scallion virus X (ScaVX), EMARAV, NMV, Chenopodium mosaic virus X 
(CMVX, also called Malva mosaic virus) and Pepino mosaic virus (PeMV). Scores of 
the alignment varied between different viruses. FMAV, FMV and EMARAV were 
taxonomically placed into the unassigned genus Emaravirus (Elbeaino et al. 2009). The 
remaining seven viruses all belonged to genus Potexvirus in family Alphaflexiviridae. 
 





4.4 Virus identification based on RT-PCR and sequencing 
4.4.1 Detection of AlsVX 
In the first-collected six samples, AlsVX was only detected in sample Pe15 (Figure 8). 
The CP gene and the triple gene block protein 3 of AlsVX are 692 nt (230 aa) and 299 
nt (99 aa) long, respectively. The amplified fragment of AlsVX was about 1100 nt long, 
which contains complete CP gene and partial of the triple gene block protein 3 (Figure 
6). The sequence of the PCR product was aligned with the sequence of AlsVX CP gene 
in NCBI. The CP sequences were 82% identical at the nucleotide level (Appendix 2) 
and  90% identical  at  protein  level.  According  to  BLASTx results,  the  virus  in  sample  
Pe15  also  had  73%  amino  acid  identity  to  the  CP  of  NMV  strain  New  Zealand,  70%  
identity  to  CP of  ScaVX,  69% identity  to  CP of  AV3,  66% identity  to  CP of  CMVX,  
64% identity to CP of PeMV, and 64% identity to CP of LeVX (Table 7; Appendix 3 
for accession number). 
 
 
Figure 8. AlsVX detection in A.tomentosum Pe15 by RT-PCR. Lane 1: negative control, 
lane 2: Pe15, lane 3: Pe14, lane 4: Pe13, lane 5: negative control, lane 6: Pe12, lane 7: 







Table 7. Percentage of nucleotide identity (upper triangle, 1033 nt) and amino acid 
identity (lower triangle) of AlsVX-Hel and other potexviruses (accession numbers in 
Appendix 3). 






NMV ScaVX AV3 CMVX PeMV LeVX 
AlsVX-Hel * 82 72 74 72 70 66 68 
AlsVX-Jap 90 * 71 70 70 68 68 72 
NMV 73 74 * 75 73 73 67 68 
ScaVX 70 73 80 * 80 71 68 67 
AV3 69 69 83 91 * 73 67 68 
CMVX 66 70 78 75 78 * 66 64 
PeMV 64 65 71 66 66 64 * 68 
LeVX 64 63 65 63 61 59 58 * 
4.4.2 Detection of FMV-Hel 
The FMV-Hel was detected in all six A.tomentosum plants of the first collection. The 
sequences of the six PCR products were identical. The sequence of FMV-Hel described 
in this study differs from other FMV strains at the nucleotide level (Appendix 4). The 
putative nucleocapsid protein gene of the FMV-Hel included in the amplified region 
was 78% identical with the FMV strain Can01, 77% identical with FMV strain Gr10, 
78% identical with FMAV-JJW2008, 69% identical with Rose rosette virus (RRV), and 
59% identical with EMARAV. At protein level, the FMV-Hel had 78%, 78%, 75%, 
74% and 52% identity with the putative nucleocapsid protein of FMV-Can01, FMV-
Gr10, FMAV-JJW2008, RRV and EMARAV, respectively (Table 8). 
 
Table 8. Percentage of nucleotides identity (upper triangle, 518 nt) and amino acid 
identity  (lower  triangle)  of  FMV-Hel  and  other  related  viruses  (accession  numbers  in  
Appendix 3). 











FMV-Hel * 78 77 78 69 59 
FMV- Can01 78 * 94 98 70 66 
FMV-Gr10 78 100 * 94 69 64 
FMAV-JJW2008 75 99 99 * 70 63 
RRV 74 65 62 75 * 58 





FMV shares high amino acid identities with EMARAV, Pigeonpea sterility mosaic 
virus (PPSMV) and Maize red stripe virus (MRSV) (Elbeaino et al., 2009). A 
phylogenetic tree was constructed to demonstrate relatedness of members in genus 
Emaravirus (Figure 9). According to the phylogenetic analysis, the FMV-Hel from 
Helsinki is only distantly related to FMV strains from Canada (FMV-Can01), Italy 
(FMV-Gr10) and USA (FMAV-JJW2008), and has even further evolutionary distance 
to other Emaravirus members (Figure 9).    
 
Figure 9. Phylogenetic analysis of the RNA3 putative nucleocapsid encoding region of 
members of genus Emaravirus (accession numbers in Appendix 3).  
4.5 Distribution and variability of the FMV-Hel in Helsinki area 
The FMV-Hel was detected in A.tomentosum plants with virus-like disease symptoms in 
different places of Helsinki (Table 9; Figures 10-14). However, all these samples except 
Pe15 were AlsVX-free. Symptoms and the results of PCR-based detection of the FMV-
Hel are shown in Table 9. The typical symptoms of A.tomentosum infected with FMV-
Hel were yellowing of veins in the leaves. Furthermore, leaf mosaic appearing along to 
veins or distributed on the whole leaf was also a typical symptom in the severely 









Table 9. PCR-based detection of the FMV-Hel, and the foliar symptoms observed in 




















Pasila Pa1 +  +     
 Pa2 + + +  +   
 Pa3 + + +     
 Pa4 + + +     
Viikki Vi1 -     +  
 Vi2 (nsa) -       
 Vi3 -     +  
 Vi4 + +      
 Vi5 + +    +  
 Vi6 -     +  
 Vi7 (ns) -       
 Vi8 + +    +  
Pihlajamäki Pih1 + + +     
 Pih2 +  +     
 Pih3 -      + 
 Pih4 (ns) -       
 Pih5 -      + 
 Pih6 -     +  
 Pih7 + + +   +  
 Pih8 + + +     
 Pih9 + +      
 Pih10 + +      
 Pih11 + +      
 Pih12 + +      
 Pih13 + + +     
 Pih14 + + +     
 Pih15 + +      
 Pih16 + + +     
 Pih17 + +    +  
 Pih18 + + +     
 Pih19 +  +     
Hämeenlinnanväylä H1 + +      
 H2 -   +    
 H3 -   +    
 H4 + +      
 H5 +  +     
 H6 + + +     
 H7 + + +     
 H8 + +    + + 
Rapakiventie R1 + +      
 R2 + +      
 R3 +  +   +  
 R4 + +      
 R5 + +    +  
Rapakiventie R6 + + +     
 R7 +       
 R8 + + +     
 R9 +  +     
 R10 + +    +  
 R11 + +      
 R12 + +   +   
 R13 + +      





Figure 10.  Leaves of A.tomentosum plants  Vi1-8.  Sampled  in  Viikki  on  18th  May,  
2011. Red color indicates that the leaf was infected with the FMV-Hel. 
 
 
Figure 11.  Leaves of A.tomentosum plants H1-8. Sampled in Hämeenlinnanväylä on 






Figure 12.  Leaves of A.tomentosum plants Pa1-4. Sampled in Pasila on 6th June, 2011. 
Red color indicates that the leaf was infected with the FMV-Hel. 
 
Figure  13.   Leaves  of  A.tomentosum plantsR1-13. Sampled in Rapakiventie on 26th 







Figure 14. Leaves of A.tomentosum plants Pih1-19. Sampled in Pihlajamäki on 16th 






In order to study the differences of nucleotide sequences between virus isolates 
collected from different places, PCR products of two samples from each sampling site 
were randomly chosen and sent to Haartman Institute for sequencing. The viral 
sequences from different individual samples were identical, which suggested that the 







AlsVX had only been isolated previously from Alstroemeria (Alstroemeria spp., 
Alstroemeriaceae) in Japan. This study is the first report of the virus occurrence outside 
Japan. The viral isolate detected in A.tomentosum in Helsinki showed 82% CP 
nucleotide sequences identity and 90% CP amino acid sequence identity with the isolate 
described in Japan, which is well above the species demarcation limit (76.3% nt identity 
and 88.8% aa identity) in genus Potexvirus (Adams et al.,  2004).  AlsVX  was  first  
described in 2005 (Fuji et al., 2005) from an alstroemeria plant (cultivar Virginia) in 
Hokkaido. The virus caused systemic symptoms of mosaic and necrotic streaks in 
Alstroemeria. AlsVX was placed into family Flexiviridae, genus Potexvirus, according 
to particle morphology and physical properties. It has flexuous viral particles which 
resemble  potexviruses,  and  contains  a  3’-terminal  poly(A)  tail.  The  genomic  RNA  of  
AlsVX-Jap is 7009 nucleotides excluding the poly(A) tail. As other members of the 
genus, it contains 5 open reading frames (ORFs) (Figure 6) (Fuji et al., 2005).  
Fuji et al. (2005) concluded that AlsVX was closely related to NMV and ScaVX. 
This suggests that reads and contigs of AlsVX-Hel are possible to be aligned to the 
conserved region of sequences of potexviruses (Table 5; Table 6). The motif 
“GGAAAA” of AlsVX is identical to ScaVX (Fuji et al., 2005). The motif had been 
proposed to be an element of RNA replication or protein translation, and it is in the 
beginning  of  the  AlsVX’s  5’  untranslated  region  (97  nt  of  5’-UTR).  Other  conserved  
motifs in potexviruses such as “ACUUAA”, which is supposed to be a cis-acting 
element affecting viral RNA synthesis, and a putative polyadenylation signal sequence 
“AAUAAG” (Cotillon et al., 2002), were found in the 3’-UTR (nt 6955-6960) of 
AlsVX (Fuji et al., 2005). Comparison of amino acid similarity and identity of AlsVX-
Jap and other potexvirus demonstrated that ORFs 2, 3 and 5 of AlsVX shared the 
highest similarity and identity with the corresponding ORFs of NMV, and ORFs 1 and 4 
were highly similar to ScaVX.  
With limited information about AlsVX, it is hard to explain why the virus existed in 
A.tomentosum in Helsinki. In a total of 58 tested plants, only one plant contained AlsVX.  
This study is also the first report of the occurrence of the FMV-Hel in Finland. 
FMV has been reported in Italy, Canada, United States, Turkey, Iran and Egypt since it 
was characterized in 2009. The FMV-Hel which exists in A.tomentosum was supposed 




However, a recently characterized negative-strand RNA virus (RRV) is also closely 
similar to the FMV-Hel according to the results of BLASTx. Four of the genomic RNAs 
of RRV share 68%, 51%, 60%, 59%  identity with the corresponding FMV RNAs, and 
the  RNA1  and  RNA2  share  49  %  and  40  %  identity  with  the  EMARAV  respectively  
(Laney et al., 2011). Therefore, RRV was placed into genus Emaravirus, which already 
contains EMARAV, FMV, Maize red stripe virus (MRSV) and Pigeonpea sterility 
mosaic virus (PPSMV) (http://www.dpvweb.net/notes/showgenusmembers. 
php?genus=Emaravirus). RRV causes excessive lateral shoot growth, excessive 
thorniness, witches’ broom, leaf proliferation and malformation, mosaic, red 
pigmentation and plant death in Rosa multiflora in USA.  
The FMV-Hel was mostly found in A.tomentosum growing at the edges of 
woodland and road. The virus transmission mechanism of FMV is not clear yet, but 
according to the results of this study, two means of transmission can be suggested. One 
presumption  is  that  the  virus  could  be  transmitted  by  a  vector.  Elberaino et al. (2009) 
indicated that viruses from genus Emaravirus are all vectored by eriophyid mites. 
Eriophyid mites are among the smallest mites, with less than 0.3 mm long (Graham, 
2004). The tiny size facilitates eriophyid mites travelling between hosts by wind, water, 
animals and humans.  
The second possibility is that the FMV-Hel is seed-borne, since isolates from 
different areas of Helsinki are highly identical (Appendix 5). The seeds of the plant 
mature in the second growth year after flowering and are equipped with hooked bristles, 
which help seeds to adhere to people’s clothes and animals’ skin for long distance 
dispersal.  
Deep-sequencing of siRNA has been proven to be very useful for detection of 
unknown viruses, strains and isolates. It can be used not only for viral detection, but 
also for recovery of viral genomic RNA sequences. Kreuze et al. (2009) successfully 
recovered viral genomes by assembling contigs from siRNA. However, in this study, 
neither AlsVX-Hel nor FMV-Hel viral genomes were recovered completely 
(Appendixes 6 & 7). The reason might be that less siRNA than expectation was 
obtained. It is possible that the plants did not produce siRNA abundantly, or the 
protocol used is not good enough for siRNA extraction from A.tomentosum.       
Analysis with Velvet program indicated that the largest numbers of siRNA reads 
aligned  to  AlsVX,  which  means  that  AlsVX  should  have  the  highest  concentration  in  




sample by nested-PCR after RNA was reverse transcribed. In comparison, FMV-Hel 
which had lower alignment scores was detected in all individual samples by normal RT-
PCR. The conflict between computational analysis and laboratory practice might be that 
siRNAs derived from AlsVX were more abundant and the viral RNA was highly 
degraded in the plant, whereas the case with the FMV-Hel was opposite to AlsVX. 
Therefore, in siRNA deep-sequencing results, the siRNA of AlsVX were in higher 
concentration than FMV-Hel. 
MAQ and Novoalign are efficient tools for aligning siRNA with existing viral 
genomes. However, they are not powerful enough if the tested sequence greatly differs 
from the reference sequence. In this study, FMV-Hel differed from other FMV strains. 
The differences between the reference sequence and the sequence of the virus in the 
sample also increased the difficulties in primer design, so the whole region of the FMV 
putative nucleocapsid protein gene could not be amplified. The amplified partial 
fragment  of  FMV-Hel  putative  nucleocapsid  gene  (525  nt)  was  compared  with  FMV-
Can01, FMV-Gr10 and FMAV-JJW2008 (Appendix 4). The differences (75% -78% at 
nucleotide level) suggested that the FMV-Hel in Helsinki is a new strain of FMV, or a 
new virus. 
Research on discovery of viruses from wild plants enriches the knowledge on viral 
biodiversity. Deep-sequencing of vsiRNA is simple to be conducted and effectively 
works for viral detection from wild plants. However, the limitation is that it can be used 
only for detecting viruses which are related to known viruses, because known sequences 
are necessary to be used as reference. For detecting a novel virus completely unrelated 





6 CONCLUSIONS  
siRNA deep-sequencing method was successfully applied to virus detection in diseased 
plants of A.tomentosum in Helsinki. The plants growing in nature with yellow vein and 
mosaic symptoms contained two viruses: Alstroemeria virus X and Fig mosaic virus-
Hel,  which  have  never  been  reported  in  Finland.  AlsVX-Hel  only  existed  in  one  plant  
sampled in Pihlajamäki; however, the FMV-Hel had a wide distribution in Helsinki. 
This study also revealed differences between the known FMV strains and the FMV-
Hel detected in Helsinki. The partial sequence of the putative nucleocapsid protein gene 
was different from other FMV strains, which hinted that the FMV-Hel might be a new 
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INGREDIENTS OF BUFFERS AND SOLUTIONS 
 
Extraction buffer for DNA (250 ml) 
25 ml Tris-HCl, pH 8.0 (1 M stock) 
70 ml Sodium chloride (5 M stock) 
10 ml Ethylenediaminetetraacetic acid (EDTA) (0.5 M stock) 
5 g Cetyl trimethylammonium bromide (CTAB)  
Add sterile H2O to 250 ml 
0.5-1% ?-mercaptoethanol (add just before use) 
 
Tris-ethylenediaminetetraacetic acid (TE) buffer (1L) 
10 ml Tris-HCl, pH 8.0 (1 M stock) 
2 ml Sodium EDTA (0.5 M stock) 
Add sterile H2O to one litre. 
 
Homemade Trizol (1L) 
380 ml Phenol pH 4.3 (38%, Sigma P4682) 
118.6 g Guanidine thiocyanate (Sigma G9277 or Fluka 50981) 
76.12 g Ammonium thiocyanate (0.4 M, Fluka O9938) 
33.4 ml Sodium acetate pH 5.0 (3 M stock) 
50 ml Glycerol 






APPENDIX 2:  
COMPARISON OF THE COAT PROTEIN GENE BETWEEN 
AlsVX-Hel AND AlsVX-Jap 
 
AlsVX-Hel        TGGGACAAGACTATTTCTTACTTCCGCCCTTCTGACCCTATCACCCACTCAAATAAATGG 60 
AlsVX-Jap        GGCACCAAAACTGTCTCTTACTTTCGCCCTTCTGACCCTATCACCCACTCTAATAAATGG 60 
                  * ..***.***.* ******** **************************:********* 
 
AlsVX-Hel        CTGGCCTTCTCATCAGTCCTCACCATCAGCCTCATCATTTGGCTTTGCTCTAAATTTTCT 120 
AlsVX-Jap        CTGGCCTTCTCATCAGTCATCACCATCAGCCTCATCATTTGGCTATGTTCTAAATTTTCT 120 
                 ******************.*************************:** ************ 
 
AlsVX-Hel        CCTGGTGATCGGCGGCCTCTACCTCCTGTATGTACTCACTGCCCCAGTCGCTAGAATTGG 180 
AlsVX-Jap        CCTGGTGATAGGCGGCCTCTACCTCCTGTATGCTCTCACTGCACCTCCCACTAAGGCCGG 180 
                 *********.********************** :********.**:  *.***...  ** 
 
AlsVX-Hel        GTGCGTGGTCCGTGTTACCGGAGAAAGTGTGACAATAGATAATTGCCCGGACACGGCCCA 240 
AlsVX-Jap        TTGCATCGTACGCGTGACGGGCGAAAGTGTGACCATAGATAATTGCCCGGACACAGCTTT 240 
                  ***.* **.** ** ** **.***********.********************.**  : 
 
AlsVX-Hel        AATAATGGAAAAGTTTAACCTCGCTCCTTGGAACGGGGTTAAGTTTCCAAAAGATTGAAA 300 
AlsVX-Jap      AATAATGGAAAAATTCAATCTCGCTCCTTGGAACGGGGTTAAGTTTCCAAAAGAATGAAA 300 
                 ************.** ** ***********************************:***** 
                                                   ?Coat protein start 
AlsVX-Hel        ATTTTACT---ATACCT--CACCT-CCAATTACCTATGGCAGGAGATAACCCTAACCCCC 354 
AlsVX-Jap        ATTTTAATTATAAACCAGACACCTTTCTTAATTAAATGGCAGGAGAAAACACACCACCCA 360 
                 ******.*   *:***:  *****  *::::: .:***********:***.*:...***. 
 
AlsVX-Hel        AAGCAACCAAAGCACCCACCGGGTCAGCAGCCGACCTCGCCAACCCCAACCGCAGCCCCA 414 
AlsVX-Jap        CCCCCCCGACAGCACCAGCCGGCTCCGCTGCCGACCTGGCTAACCCCAACCGCAGCCCCA 420 
                 .. *..* *.******..**** **.**:******** ** ******************* 
 
AlsVX-Hel        CCGTAGCTGACCTGGCCCAACTCAAGTACCAATCGACTACCACATCAGTTGCCACACCCC 474 
AlsVX-Jap        CAGTTTCCGACCTAGCTAAACTCAACTACCAATCGACCACCACCTCAGTCGCCACCCCAG 480 
                 *.**: * *****.** .******* *********** *****.***** *****.**.  
 
AlsVX-Hel        AAGAAATAGCCGCACTCGGTGTACTATTCACCAACGCCGGCGTCGACCCCAACTCTGTAC 534 
AlsVX-Jap        AGGAGATCACTGCCCTTGGTGTGCTCTTCACTAGCGCCGGCGTAGACCCCAACTCAGTTC 540 
                 *.**.**..* **.** *****.**.***** *.*********.***********:**:* 
 
AlsVX-Hel        CCCTCGCCATGTGGGACCTTGCCCGCGCCTACGCTGACGTCCAGTCAAGCCGCAGTGCTA 594 
AlsVX-Jap        CACTGGCCATGTGGGATTTAGCTCGGGCCTATGCTGACGTTCAGTCCAGCCGCAGTGCCA 600 
                 *.** ***********  *:** ** ***** ******** *****.*********** * 
 
AlsVX-Hel        TGCTCGTAGGTTCCACCCCTTCCAACTCAGCCATCACTCGCCAAACTCTAGCCCGGAAAC 654 
AlsVX-Jap        TGCTAGTGGGGTCCACTCCATCCAACAAATCCATCACCCGTCAGACCCTTGCCCGCAAGC 660 
                 ****.**.** ***** **:******:.* ******* ** **.** **:***** **.* 
 
AlsVX-Hel        TCGAACAGGTCAACATCACCCCCCGCCAGTTCTGCATGTACTTCGCTAAGGTAGTGTGGA 714 
AlsVX-Jap        TGGATCAAGTCAACATCACGCCACGCCAATTCTGCATGTACTTCGCAAAAGTCGTGTGGA 720 
                 * **:**.*********** **.*****.*****************:**.**.******* 
 
AlsVX-Hel        ATATCCTCATCACCTCCAACGTAGCACCTGCTGGTTGGGCTAAACTAGGGTACCCTGAGG 774 
AlsVX-Jap        ATATCCTGATCAGCAGCAACACCGCACCCGCCGGCTGGGCAAAGTTGGGGTACCCCGAAG 780 
                 ******* **** *: ****. .***** ** ** *****:**. *.******** **.* 
 
AlsVX-Hel        AGTGCAAATTCGCCGCTTTCGATTTCTTCGACGGCGTCCTATCCCCGGCAGCACTCGAAC 834 
AlsVX-Jap        AATGCAAGTTCGCTGCATTCGACTTCTTCGACGGTGTCCTCTCCCCAGCCGCACTTGATC 840 
                 *.*****.***** **:***** *********** *****.*****.**.***** **:* 
 
AlsVX-Hel        CCGCTGATGGCCTTGTTCGACAACCCAACACCCGTGAGATACAGGCACATTCCACCGCCA 894 
AlsVX-Jap        CCGCTGACGGGCTCATCAGACAACCCAACACCCGGGAGATCCAAGCCCACTCAACGGCTA 900 
                 ******* ** ** .* .**************** *****.**.**.** **.** ** * 
 
AlsVX-Hel        AATTTGGAGCTCTAGCTCGCCAACGCATCAGCAATGGCAACTATGTCTCCACTCTTGCCG 954 
AlsVX-Jap        AGTTTGGAGCTCTCGCCCGCCAACGCATCAGCAATGGCAATTTCGTCTCAACACTCGCCG 960 





AlsVX-Hel        AAGTCACCCACGGCAGAGTTGGTGGGGTCAATGCCATGTACTCCATCGAAGCCCCCCCAG 1014 
AlsVX-Jap        AGGTCACCCACGGCAGAGTCGGAGGTGTCAATGCCATGTACTCCATCGAAGCCCCCCCAG 1020 
                 *.***************** **:** ********************************** 
                        ?Coat protein end 
AlsVX-Hel        AAGCCTAAGGCCTTTCTCCTTGCCCAACTTAAATAGAGATAGAACTGGTGTGGTGTGTGT 1074 
AlsVX-Jap        AAGCCTAAG-CCTTTCTCCTTGCCCAACTTAAATA-AGGAGGTGTTTTTCTACAGT-TTT 1077 
                 ********* ************************* **.:.*:. *  * *. :** * * 
 
AlsVX-Hel        GGAGAAGCCAGATTAAGTCGAAAGCGAT 1102 
AlsVX-Jap        ATTTTCACTAATATACTATGTGTGTGTT 1105 





APPENDIX 3:  
ACCESSION NUMBERS OF THE VIRAL SEQUENCES AND 







Alstroemeria virus X-Japan (AlsVX-Jap) AB206396.1 BAE44215.1 
Narcissus mosaic virus (NMV) AY225449.1 AAP51016.1 
Scallion virus X (ScaVX) AJ316085.1 CAC87090.1 
Asparagus virus 3 (AV3 ) AB304848.1 BAG12162.1 
Chenopodium mosaic virus X (CMVX) DQ660333.1 ABG48664.1 
Pepino mosaic virus (PeMV) AY509926.1 AAS79813.1 
Lettuce virus X (LeVX) AM745758.1 CAN88812.1 
Fig mosaic virus-Can01 (FMV-Can01) HQ703345.1 AEI98678.1 
Fig mosaic virus-Gr10 (FMV-Gr10) FM991954.1 CAX21211.1 
Fig mosaic-associated virus (FMAV-JJW2008) FJ211073.1 Not accessible 
Rose rosette virus (RRV) HQ891906.1 ADZ55370.1 
European mountain ash ringspot- 
associated virus (EMARAV) 
GU563319.1 ADM35031.1 





APPENDIX 4:  
COMPARISON OF AMPLIFIED PARTIAL SEQUENCE OF 
NUCLEOCAPSID GENE OF FMV-Hel WITH FMV STRAINS Gr10, 
Can01 AND WITH FMAV JJW2008 
 
FMV_Gr10          GTTGTTAAAGAGCTTAATGATAGTACAG---------TTGATAATGTTGTTTCATTTAAC 51 
FMAV_JJW2008      GTTGTTAAAGAGCTTAATGATAGTACAG---------TTGACAATGTTGTTTCCTTTAAC 51 
FMV_Can01         GTTGTAAAGGACATGACAGAAAGTAACGTTAAGAATGTTGATAATGTTGTTTCTTTTAAC 60 
FMV-Hel           GTTGTAAAGGACATGACAGAAAGTAACG---------TTAAGAATGTTGTATCCTTCAAT 51 
                  *****:**.** .* *.:**:****..*         **.* ********:** ** **  
 
FMV_Gr10          AAAGCATGTGCTATCATGTCAGCTGGTATACTAAAACATACCTTTGATGAGGAATTTGAC 111 
FMAV_JJW2008      AAAGCATGTGCTATCATGTCAGCTGGTATACTCAAGCATACCTTTGATGAGGAATTTGAC 111 
FMV_Can01         AAAGCATGTGCTATCATGTCAGCTGGTATACTCAAACATACCTTTGATGAGGAATTTGAC 120 
FMV-Hel           AAAGCATGTGCTATTATGTCAGCTGGTATACTCAAACACACTTTCGACGAGGAATTCGAC 111 
                  ************** *****************.**.** ** ** ** ******** *** 
 
FMV_Gr10          TGGAAACTATCAAAATATGTAAAGACGAACAACACTACCAAAGTGATTCCTGATGTGAAG 171 
FMAV_JJW2008      TGGAAACTATCAAAATATGTAAAAACGAACAATACTACTAAGGTGATTCCTGATGTAAAA 171 
FMV_Can01         TGGAAATTATCAAAATATGTAAAGACGAACAATACTACTAAGGTAGTTCCTGATGTGAAA 180 
FMV-Hel           TGGAAGACTGGAAAATATGTTAGTACTGAGAACAAAGCAAAAGTTGTTCCTAATGCTCAG 171 
                  *****.  :  *********:*. ** .* ** *.:.* **.** .*****.***  .*. 
 
FMV_Gr10          ATCATAAATCGACTAGCAGGTCAGATGGGCTTGTCAGCTGGTAATCCATATTACTGGATG 231 
FMAV_JJW2008      ATCATAAATAGACTAGCGGGTCAGATGGGCTTATCAGCTGGTAATCCATATTACTGGATG 231 
FMV_Can01         ATCATAAACAGACTAGCGGGTCAGATGGGCTTATCAGCTGGTAATCCATATTACTGGATG 240 
FMV-Hel           ATTATAAACAGACTTGCTGGCCAAATGGGTTTAGCACCTAGTTCACCTTATTACTGGATG 231 
                  ** ***** .****:** ** **.***** **. ** **.**:.:**:************ 
 
FMV_Gr10          ATTGTGCCAGGTTATGAATTCTTATATGAACTTTATCCAGCTGAGGTATTAGCATACACT 291 
FMAV_JJW2008      ATTGTGCCTGGTTATGAATTCTTGTATGAACTGTATCCAGCTGAGGTATTAGCATACACT 291 
FMV_Can01         ATTGTGCCTGGTTATGAATTCTTGTATGAACTGTATCCAGCTGAGGTATTAGCATACACT 300 
FMV-Hel           ATAGTACCTGGTTATGAATTCTTGTATGAACTGTACCCAGCTGAGGTATTAGCATACACT 291 
                  **:**.**:**************.******** ** ************************ 
 
FMV_Gr10          CTGGTGAGACTCCAATACAGGAAAAACCTAAACATACCAGATAGTATGACTGATGCTGAT 351 
FMAV_JJW2008      CTGGTAAGGCTCCAATACAGGAAAAACCTAAATATACCAGATAGTATGACTGATGCTGAT 351 
FMV_Can01         CTGGTAAGGCTCCAATACAGGAAAAACCTAAACATACCAGATAGTATGACTGATGCTGAT 360 
FMV-Hel           CTTGTGAGACTTGAATTCAGGAAGAACTTAAACATTCCTGATAAGACAACTGATGCTGAC 351 
                  ** **.**.**  ***:******.*** **** **:**:****. * .***********  
 
FMV_Gr10          ATTGTCAGTTCTCTTGTCATGAAAATGAATAGAATTCATAAACTTGAACAGACCAGCTTT 411 
FMAV_JJW2008      ATTGTCAGTTCTCTTGTTATGAAAATGAATAGAATTCATAAACTTGAACAGACCAGCTTT 411 
FMV_Can01         ATTGTCAGTTCTCTTGTTATGAAAATGAATAGAATTCATAAACTTGAACAGACCAGCTTT 420 
FMV-Hel           ATTGTTAGTTCACTTGTTATGAAAATGAACAGGATTCATAAACTTGATGTCACAACATTT 411 
                  ***** *****:***** *********** **.**************: : **.* .*** 
 
FMV_Gr10          GATGAAGCCCTAAATCTTATAGGCAAGGATAACGTATCCGAAGCTTATGTGGAACTTGCA 471 
FMAV_JJW2008      GATGAAGCCCTAAATCTTATAGGCAAGGATAACGTATCTGAAGCTTATGTAGAACTTGCA 471 
FMV_Can01         GATGAAGCCCTAAATCTTATAGGCAAGGATAACGTATCTGAAGCTTATGTAGAACTTGCA 480 
FMV-Hel           GATGATGCTATCAACACAATAGGTCAGAACAATGTGTCTGATGCTTATATTGAGTTAGCA 471 
                  *****:** .*.** . :***** .**.* ** **.** **:******.* **. *:*** 
 
FMV_Gr10          AGAGATATAGGAAGCACGAGCAAGACAAAGAGAAATGATGAAGCAATTCTTAAG 525 
FMAV_JJW2008      AGAGATATAGGAAGCACGAGCAAGACAAAGAGAAATGATGAAGCAGTTCTTAAG 525 
FMV_Can01         AGAGATATAGGAAGCACGAGCAAGACAAAGAGAAATGATGAAGCAATTCTTAAG 534 
FMV-Hel           AGAGACATAGGTACTACGAGCAAGAGCAAGAGGAATGATGAAGCTATTATGAAA 525 






APPENDIX 5:  
SEQUENCES OF FMV-Hel ISOLATES FROM DIFFERENT 
PLANTS OF A.tomentosum IN HELSINKI 
 
H5              CGTTAAGA-TGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 59 
Pih15           CGTTAAGAATGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 60 
H4              CGTTAAGAATGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 60 
Pa3             CGTTAAGAATGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 60 
Pih1            CGTTAAGAATGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 60 
Vi5             CGTTAAGAATGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 60 
Vi4             CGTTAAGAATGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 60 
Pa2             CGTTAAGA-TGTTGTATCCTTCAATAAAGCATGTGCTATTATGTCAGCTGGTATACTCAA 59 
                ******** *************************************************** 
 
H5              ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 119 
Pih15           ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 120 
H4              ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 120 
Pa3             ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 120 
Pih1            ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 120 
Vi5             ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 120 
Vi4             ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 120 
Pa2             ACACACTTTCGACGAGGAATTCGACTGGAAGACTGGAAAATATGTTAGTACTGAGAACAA 119 
                ************************************************************ 
 
H5              AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 177 
Pih15           AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 178 
H4              AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 178 
Pa3             AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 178 
Pih1            AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 178 
Vi5             AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 178 
Vi4             AGCAAAAGTTGTTCC-TAATGCTCAGATTATAAACAGACTTGCTGGCCAAATGGGGTTTA 179 
Pa2             -GCAAA-GTTGTTCCCTAATGCTCAAATTATAAACAGACTTGCTGGCCAAATGGG-TTTA 176 





H5              GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 237 
Pih15           GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 238 
H4              GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 238 
Pa3             GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 238 
Pih1            GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 238 
Vi5             GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 238 
Vi4             GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 239 
Pa2             GCACCTAGTTCACCTTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTG 236 
                ************************************************************ 
 
H5              TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 297 
Pih15           TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 298 
H4              TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 298 
Pa3             TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 298 
Pih1            TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 298 
Vi5             TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 298 
Vi4             TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 299 
Pa2             TACCCAGCTGAGGTATTAGCATACACTCTTGTGAGACTTGAATTCAGGAAGAACTTAAAC 296 
                ************************************************************ 
 
H5              ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 357 
Pih15           ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 358 
H4              ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 358 
Pa3             ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 358 
Pih1            ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 358 
Vi5             ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 358 
Vi4             ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 359 
Pa2             ATTCCTGATAAGACAACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGG 356 
                ************************************************************ 
 
H5              ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 417 
Pih15           ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 418 
H4              ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 418 
Pa3             ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 418 
Pih1            ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 418 
Vi5             ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 418 
Vi4             ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 419 
Pa2             ATTCATAAACTTGATGTCACAACATTTGATGATGCTATCAACACAATAGGTCAGAACAAT 416 





H5              GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACGAGCAAGAGCAAGAGG 477 
Pih15           GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACCAGCAAGAACAAGAAG 478 
H4              GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACGAGCAAGAGCAAGAGG 478 
Pa3             GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACGAGCAAGAGCAAGAGG 478 
Pih1            GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACGAGCAAGAGCAAGAGG 478 
Vi5             GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACGAGCAAGAGCAAGAGG 478 
Vi4             GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACGAGCAAGAGCAAGAGG 479 
Pa2             GTGTCTGATGCTTATATTGAGTTAGCAAGAGACATAGGTACTACCAGCAAGAGCAAGAGG 476 
                ******************************************** ******* ***** * 
 
H5              AATGATGAAGCTATTATGAAA 498 
Pih15           AATGATGAAGCTATTATGAAA 499 
H4              AATGATGAAGCTATTATGAAA 499 
Pa3             AATGATGAAGCTATTATGAAA 499 
Pih1            AATGATGAAGCTATTATGAAA 499 
Vi5             AATGATGAAGCTATTATGAAA 499 
Vi4             AATGATGAAGCTATTATGAAA 500 
Pa2             AATGATGAAGCTATTATGAAA 497 








APPENDIX 6:  
MAQ-RECOVERED GENOMIC SEQUENCE OF AlsVX-Hel 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAACAAACTTACACACATAACCACGA 60 
AlsVX-Jap        GGAAAATCAATTCCAACAAAACAAAACAAACTTAAAACAACATTACACACATAACCACGA 60 
                 ..    .   ..                   ..  *****..****************** 
 
AlsVX-Hel        ACCAAAATCGGTTAAAACAAAACCACTTTCGTTCATTATGTCGAAAATTAGAAACGTGTT 120 
AlsVX-Jap        ACCAAAATCGGTTAAAACAAAACCACTTTCGTTCATTATGTCGAAAATCAGAAACGTGTT 120 
                 ************************************************ *********** 
 
AlsVX-Hel        GGACAAAATCAGAGACCCATCTGTACAAACAGCAATTTGCGAAAATGCTTATGCACAAAT 180 
AlsVX-Jap        GGACAAAATCAGAGACCCATCTGTACAAACAGCAATTTGCGAAAATGCTTATGCACAAAT 180 
                 ************************************************************ 
 
AlsVX-Hel        GAGACCTGTACTCAAAGAGGCACTTGTTAAYTGCCCTTACGCACTCACCGACCTAGAAGC 240 
AlsVX-Jap        GAGACCTGTACTCAAAGAGGCACTAGTCAATTGCCCTTACGCACTAACCGATCTAGAAGC 240 
                 ************************:** ** **************.***** ******** 
 
AlsVX-Hel        CGACGCTCTAGAGAATATGGGTATTTCCGTAAATCCTTACGCGACACAGACCCACACGCA 300 
AlsVX-Jap        CGACGCTCTAGAAAATATGGGTATATCCGTAAATCCTTACGCGACACAGACCCACACACA 300 
                 ************.***********:********************************.** 
 
AlsVX-Hel        TGCAGCCTGTAAAGCAATCGAAAATCAAATGCTGCAAATAGTCGGACACCACCTCCCAAA 360 
AlsVX-Jap        CGCAGCCTGCAAAGCCATCGAAAACCAGATGCTGCAAATAGTCGGACACCACCTCCCAAA 360 
                  ******** *****.******** **.******************************** 
 
AlsVX-Hel        ATCCAAAGTTACNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 420 
AlsVX-Jap        GTCCAAAGTCACTTTCCTCTTTCTGAAGAGAAGTAAACTCCGCTACATGCGCAGAGCTGC 420 
                 .******** **...  . ... ..  . .  ..    .  . .   .. .  . . ..  
 
AlsVX-Hel        NNNNCTCAACGACCACTTTATGAACAAAAANNNNNNACCCAAAGACTTCTTCCGATATGA 480 
AlsVX-Jap        TGCTCTCAACGATCACTTCATGAACAAAAATGTGGAGCCCAAAGACTTCTTCAGATACGA 480 
                 .. .******** ***** ***********..... .***************.**** ** 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACATATCGGA 540 
AlsVX-Jap        CTCTGAAACTGTATGCGCAAACCTCAGTGCCGTATCCACCAGCATCGCATACATTTCCGA 540 
                  . ..    ... .. .      .  ...  .. .      .  . .  .****:** ** 
 
AlsVX-Hel        CACCCTACACTTCATGACTTTCGAAGAACTGGCAAATCTCTTCGAAACGAGCCCGAAGCT 600 
AlsVX-Jap        CACCCTACACTTCATGACATTCGAAGAACTTGCCAACCTCTTCGAAACGAGCCCGAAGCT 600 
                 ******************:*********** **.** *********************** 
 
AlsVX-Hel        TGACACCCTANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 660 
AlsVX-Jap        TGACACTCTGCTAGCGACTGTAGTGCTGCCCGTCGAAGCTCTGCACAAACGAACTTCACT 660 
                 ****** **. . . .  ... ... ..   .. .  . . ..       .   ..   . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 720 
AlsVX-Jap        ACACCCCGCTCTGTACTCCATCAACTACAACAAAGACGGGTTCGAATACATCCCAGGCAA 720 
                        . . ...  .   .    .        .  ..... .  .   .    ..    
 
AlsVX-Hel        NCACGGAGGAGGAGCTTATTTCCANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 780 
AlsVX-Jap        TCACGGTGGAGGAGCCTATTTCCATCCTTACGACACACTACAATGGCTCAAAGTGAGGAC 780 
                 .*****:******** ********.  ..  .      .    ... .    ... ..   
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTCCACCTCACCTTCCAAATGGT 840 
AlsVX-Jap        CCTACTCTGCAACAGTAAACACAAGGGTTTCCCTCCTTTCCACCTCACATTCCAAATGGT 840 
                   .  . ..     ..        ......   .  ..**********.*********** 
 
AlsVX-Hel        TGANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 900 
AlsVX-Jap        AGAGAGTTTAGGCGCCAACCATCTTTTCATCATAAGGCGTGGAAAATTCGAAACCCCCCT 900 
                 :**. .... .. .       . ....  .  .  .. ....    .. .         . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCCAAAAATTTTCCACCCATCNNN 960 
AlsVX-Jap        CTACCGCACCTTCTGCCGTGACACCTACGTCACATTCCCAAAAATCTTCCATCCATCCAC 960 






AlsVX-Hel        CGCCAACGCCAATAAACCGATNNNNNNNNNNNNNNNNATGCAGCTTTGGCTTTACTGCAA 1020 
AlsVX-Jap        CGCCAACGCCAACAAACCCATCCAAAAACAAAAAGCCATGCAGCTCTGGCTATACTGCAA 1020 
                 ************ ***** **             .  ******** *****:******** 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTACGCAC 1080 
AlsVX-Jap        GTCAGTCAAAGCAGTAACCGAACGGGACATCTATGCCAAAATAAGGCAAGTACTGCGAAC 1080 
                 ..  ..    .  ..    .   ...   . . ..      .  ..   ..  *.**.** 
 
AlsVX-Hel        CGAAGAACTTGAGCTTTATGANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1140 
AlsVX-Jap        CGAAGAACTTGAGCTGTACGAGCCGGCGGAGGTGGCACACATAGTAAACTACTTCTACTT 1140 
                 *************** ** **.  .. .. .....      . ..    .  .. .  .. 
 
AlsVX-Hel        NNNNNNNNNNNNNNACTCCATCACACGCTACGAAGACCTGCTATCTGGCTCWCTACTCAA 1200 
AlsVX-Jap        CATAGCGAACCTCCACTCCATCACTTGCTACGAAGACCTGCTGTCAGGGTCACTACTCAA 1200 
                   . . .    .  **********: ****************.**:** ** ******** 
 
AlsVX-Hel        ACGGATGACTGTCCCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGAGGAAA 1260 
AlsVX-Jap        AAGGATGACAGTCCCAATACGCACGGCCATCACAAAGTTCGTCGAGGTCTTTCGCGGAAA 1260 
                 *.*******:*****  .  .   ..   .      ... .. . ... ... *.***** 
 
AlsVX-Hel        GAATGACTTCGTCAAACTCNNNNNNNNNNNNNNNNGGGACAACTTCTCCTACAGCATCAA 1320 
AlsVX-Jap        GAATGACTTTGTCAAACTTTTGGATGCTCTCAAGTGGGACAACTTTACCTACAGCATCAA 1320 
                 ********* ******** .... .. . .   ..********** :************* 
 
AlsVX-Hel        CCCGGAAGANNNNNNNNNNNNAATGGACTCACATCAGGTAAACCACTTGGTGGAAGAGTA 1380 
AlsVX-Jap        ACCGGAGGACATGACCACCAAAATGGACTCACACCAGGTCAACCACCTCGTGGAAGAGTA 1380 
                 .*****.**  ..        ************ *****.****** * *********** 
 
AlsVX-Hel        TGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1440 
AlsVX-Jap        TGGCATACCCATCAAAGAAGCTGAAGCGACCATCGCTCAGCTACACCGCGAACCAGAACT 1440 
                 ***  .     .    .  . ..  . .    . . .  . .     . .     .   . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1500 
AlsVX-Jap        GCTCAACGACGCGGACTTGGACTCCCCACCCATGGTGGATTTCCTCGGACGCACTACATA 1500 
                 . .    .  . ..  ....  .         ...... ...  . ..  .   .   .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1560 
AlsVX-Jap        CGAGCCCTTTAACTATCCCAGAACCACAACCCCGACAGACCCCAAGCCAGCCGCCACAAC 1560 
                  . .   ...   . .    .            .   .       .   .  .        
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1620 
AlsVX-Jap        CGCTGACGACTCCGCCAGCTGTTCCAAACCGCCCAACTCCGCAGCTGGGACCAGCCCGAG 1620 
                  . ..  .  .  .   . ....       .      .  .  . ....    .   . . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1680 
AlsVX-Jap        CCCCAACCACACGCAACCCGAGAAGCTGAAACCCGATGCACAACCCACTCAGGACTCCGC 1680 
                             .      . .  . ..      . ..          .  ..  .  .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1740 
AlsVX-Jap        CACAATCCCCGTCCACGTCTCAGGCTGGGAAAGAGAGCCCTTCGACTATGTGTTCCACAC 1740 
                      .    ..    .. .  .. ....   . . .   .. .  . ......       
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCAGCTTTCTTAAGCACCCGACAGGACAT 1800 
AlsVX-Jap        ATCGCAGAGCCAACAACTACGGGGACGCAAAGCAGCCTTCCTAAGCACCCGACAAGACAT 1800 
                  . .  . .        .  ....  .    ***** *** *************.***** 
 
AlsVX-Hel        CGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1860 
AlsVX-Jap        AGACTACGGCCATGACAAAATCCGATATGACACAAACCCCTGGAACGAGATACTGACTGA 1860 
                 .*  .  ..   ..      .  . . ..           ...   . . .  ..  ..  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1920 
AlsVX-Jap        CTTTCTCAGAACTGTGGGTTTCCAAGCCAACGCCGTCCTGATTCAAGTCTATGAAGCTAA 1920 
                  ... .  .   .........    .     .  ..  .. ..   .. . ..  . .   
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1980 
AlsVX-Jap        CGCAGGCATACCATGGCACAGAGACGACGAAAAGTGCTACGAAAAAGATGCCATTCTCAC 1980 
                  .  ..  .    ...    . .  .  .    ... .  .     . ..   .. .    
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2040 
AlsVX-Jap        GCTCAACTTCGGCACAGCCACCTTTGAGTTCTCAAATGGCACTAAGCTGCACCTGACCGA 2040 
                 . .    .. ..    .     .... ... .    ...   .  . ..    ..   .  
 
AlsVX-Hel        NNNNTGCCACTTCATGATGTCAGGCAAATGGCTNNNNNNNNNNNNNNNNNNNNNNNNNNN 2100 
AlsVX-Jap        CGGGTGTCACTTCATAATGTCAGGCGAATGGCTGGACCTCAAACACCGGGTAACGAACTG 2100 






AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2160 
AlsVX-Jap        CAGCGCTGACCGCATGTCCCTCACTTTCCGTGTGCACAAACAGGACATGTTCGGCCACCC 2160 
                   . . ..   .  ...   .   ...  .....        ..   .... ..       
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2220 
AlsVX-Jap        CATCCCAAAAACTACCCTGGTGCCCGAACAACAACCAGAAGTTGACGCCGGTGTCGACAA 2220 
                   .         .    .....   .           .  ....  .  ..... .     
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2280 
AlsVX-Jap        TCACAACCTGCCAAAAGAAACGCCAGCCCAAGAACCAAGTGAGGCCAGCACAGAAAGTGG 2280 
                 .       ..      .    .   .     .      ... ..   .    .   .... 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2340 
AlsVX-Jap        GCCCAACACCACAAAGCCAGCCCCATTCGTGAGCCAGAGACAGAACACGCGCTCCCCCGA 2340 
                 .              .   .     .. ... .   . .   .     . . .     .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2400 
AlsVX-Jap        GGAAAAACCCACGGTTACTGCCGTGCCCTGGGAAGCATGGAAGCCACTCCTCAACAACCA 2400 
                 ..          ....  ..  ...   ....  .  ...  .    .  .          
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2460 
AlsVX-Jap        CGGTTTCAAAGCCGATGAACAGCAACTCAATCCCGAGGGCTTCCTCATACTCCCAATTTT 2460 
                  .....    .  . ..    .    .   .   . ... ..  .  .  .     .... 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2520 
AlsVX-Jap        AGATGTACACAAGGTGCCCCACTCCAAATTCCCAGACACCGTCCCAGCAAAGCTGCAAGA 2520 
                  . ...      ....      .     ..    .     ..    .    . ..   .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTACAACACCAAAGAGCCGC 2580 
AlsVX-Jap        CACCCTCACCCAAATGAAACGCTTTCCCGTCGACATCACCATCCAGCACCAAAGAGCCGC 2580 
                      .        ..    . ...   .. .   .     *.**.************** 
 
AlsVX-Hel        AGCCTACGCTTCAGACATTAAAAACAACCGNNNNGGCAAACTACTCAGCTCCATGGACAA 2640 
AlsVX-Jap        AGCCTACGCTTCCGACATCAAAAACAACCGAACAGGCAAGCTACTTAGCTCCATGGACAA 2640 
                 ************.***** ***********    *****.***** ************** 
 
AlsVX-Hel        CAAATGGAAAGCCAGCTTTGCCTACAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2700 
AlsVX-Jap        CAAATGGAAAGCTAGCTTTGCATACAAGATGCAACACGAAGACATAACCCTGACTGGTAC 2700 
                 ************ ********.*****. ..      .  .   .     ..  ....   
 
AlsVX-Hel        NNNNNNNNNNNNNNNCGGAGGTTCGGGCAAAAGTCACGCGATCCAACANNNNNNNNNNNN 2760 
AlsVX-Jap        TGTGATCCATGGGTGTGGAGGTTCCGGCAAAAGTCACGCCATTCAACAGTTCATCCGGAC 2760 
                 .... .   ...... ******** ************** ** *****...  .  ..   
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCAACGGTCGAGCTGAGAAACGA 2820 
AlsVX-Jap        CATTCCTAACGACAACAACACCATAACGGTCGTCACCCCAACGGTCGAGCTGCGCAACGA 2820 
                   ..  .   .            .   ... ..    ***************.*.***** 
 
AlsVX-Hel        TTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCGAGAAAGCGAT 2880 
AlsVX-Jap        CTGGAGCACCAAATTACCACTCTCACCACCAGAGATGTTCAAGACGTTCGAAAAAGCGAT 2880 
                  *.. .       ..     . .        . . ....   .  ...***.******** 
 
AlsVX-Hel        CACCCAACCCTGTAACCCCATCGTCGTCTTCGACGACTACACCAAAATGCCACCCGNNNN 2940 
AlsVX-Jap        CACTCAACCCTGTAACCCCGTCGTTGTTTTCGACGACTACACCAAGATGCCCCCCGGCTA 2940 
                 *** ***************.**** ** *****************.*****.****. .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACCGGCGACAG 3000 
AlsVX-Jap        CATCGAAGCAGTGTGTATGCACCACCGCCAGATCGAATTCGTGATACTCACCGGGGACAG 3000 
                   . .  .  ...... ..       .   . . .  .. ... .  . ***** ***** 
 
AlsVX-Hel        CAAGCAGAGCGTGTACCACGAAACCAATACNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3060 
AlsVX-Jap        CAAACAGAGCGTGTACCACGAAGCCAACACTGAGGCCTACATCTCATCGATGATAGAGGC 3060 
                 ***.******************.**** **.. ..  .   . .  . . .. . . ..  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCCACCCACCGTAACGTCAA 3120 
AlsVX-Jap        CGTTGAAGTTTTCGAGCCCTTCTGCGAGTTTTACCTAAATGCCACACACCGGAACGTCAA 3120 
                  ....  ..... . .   .. .. . .....   .   .*****.***** ******** 
 
AlsVX-Hel        AGACCTTGCCAACAAGCTNNNNNNNNNNNNNNNNNNNNNNNNNNCTCTGAAAATCACCAT 3180 
AlsVX-Jap        AGACCTTGCCAACAAACTCGGAGTCTACTCAGAAAGACAGGGTTCCCTGAAAATCACCAT 3180 
                 ***************.** .. .. .  .  .   .   .....* ************** 
 
AlsVX-Hel        GGCGTCACACCACCTCAAACAGTCCNNNNNNNNNNNNNNNNNNCCATCAACCATGAAACG 3240 
AlsVX-Jap        GGCATCACACCACCTCAAACAATCGCGCATCCCACTGTTGGTGCCTTCCACCATGAAACG 3240 






AlsVX-Hel        CAACGCCATGTTGGACATAGGCCACCGCTGCATGACGTACGCTGGNNNNNNNNNNNNNNN 3300 
AlsVX-Jap        CAACGCAATGCTCGACATAGGCCACCGCTGCATGACCTACGCGGGATGCCAAGGCCTTAC 3300 
                 ******.*** * *********************** ***** ** ..    ..  ..   
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCAACACTGCTCAGAGAGAGTCTT 3360 
AlsVX-Jap        CGCACCCAAAGTCCAAATCTTGCTGGATCAACACACACAACACTGCTCGGAAAGAGTCTT 3360 
                  .        ..     . ... ... .         ***********.**.******** 
 
AlsVX-Hel        GTACACYGCATTATCNNNNNNNNNNGACAGCATACACTTCATCAACANNNNNNNNAACTC 3420 
AlsVX-Jap        GTACACTGCACTATCTAGAGCGGTTGACAGCATTCACTTCATAAACACCGGGCCCAATTC 3420 
                 ****** *** ****. . . ....********:********.****  ...   ** ** 
 
AlsVX-Hel        AACAGACTACTGGCAGAAACTGGACAGCACACCNTACCTCAAGGCCTTCATCGACACNNN 3480 
AlsVX-Jap        AACCGACTACTGGCAGAAACTGGATAGCACCCCGTACCTCAAAGCTTTCATCGACACACA 3480 
                 ***.******************** *****.**.********.** ***********    
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3540 
AlsVX-Jap        CCGAGACGAGAAAACGGAGATGTACAACTCACAACCAGCAGACGACAGCCCAACGCCGGT 3540 
                   . .  . .     .. . ...     .        .  .  .   .      .  ... 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3600 
AlsVX-Jap        CCCAGCCCCGAAGACCCATTTTCCCCCAGCTCCCAGTACCCTGCTGGAAAACATGGTCGA 3600 
                     .    .  .     ....      . .    ..    .. ...      .... .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3660 
AlsVX-Jap        AACCCTCCCCGACAAGGAAGCGAGGGAGATTTATAACAAGAGCCTAGGGTACAGCAACGC 3660 
                      .    .    ..  . . ... . ... .     . .  . ....   .    .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3720 
AlsVX-Jap        GATCCAAACTCAGGACCCCGTCGTTCAACTGTTTCAACACCAGCAAGCCAAGGATGAAAC 3720 
                 . .      .  ..     .. ...    .....        .   .    .. ..     
 
AlsVX-Hel        NNNNNNNAGGGCCACCATCGAAGCAAGACTCTCNNNNNNNNNNNNNNNNNNNNNNNNNNN 3780 
AlsVX-Jap        GCTATACTGGGCCACCATCGAAGCACGACTTTCCATCTCCACCCCAGAAGCGAACCTTCG 3780 
                 . . .  :*****************.**** **  . .        .  . .    .. . 
 
AlsVX-Hel        NGAATTCAACCTCAAGAAAGATGTGGGTGATGTACTCTTCGCCAACTATGCNNNNNNNNN 3840 
AlsVX-Jap        AGAATTTAACCTGAAGAAAGATGTGGGAGACGTGCTCTTCGCCAACTATGCTCAGATCAT 3840 
                  ***** ***** **************:** **.*****************.  . .  . 
 
AlsVX-Hel        NNNNNNNNNNNCAGAACCCGTGCCATTTGACGACCGAATGTGGGAAATCAGCGAAACGGA 3900 
AlsVX-Jap        GCATCTACCCTCAGAACCCGTCCCCTTTGACGACAGAATGTGGGAGATCAGCGAAACAGA 3900 
                 .  . .    .********** **.*********.**********.***********.** 
 
AlsVX-Hel        AGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3960 
AlsVX-Jap        AGTTCGTAACACCTACCTTTCCAAGCCCATAGGCAACCTGGTCAATGCCGCCACACGACA 3960 
                 ***. ..      .   ...    .    . ..     ....   ..  .      .    
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTTCCAATGGGTCAAGAA 4020 
AlsVX-Jap        AAGCCCAGACTTCAATCCAAACAAAATCGCACTCTTTCTGAAGTCCCAGTGGGTCAAGAA 4020 
                   .    .  ..   .          . .   . ... ..  .* ***.*********** 
 
AlsVX-Hel        ACCANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4080 
AlsVX-Jap        ACCAGAGAAACTGGGGGCGCTGAAAGTCAAACCTGGTCAGACTGTCGCCTCCTTCATGCA 4080 
                 ****. .    ...... . ..   ..      ....  .  ... .  .  ..  ..   
 
AlsVX-Hel        NNNNNNNNTGATGCTGTACGGCACGATGGCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4140 
AlsVX-Jap        GGAAACTGTCATGCTCTACGGCACGATGGCCAGGTATCTGAGGAAACAGAGACAAAGATT 4140 
                 ..    ..* ***** **************  ... . .. ..     . .     . .. 
 
AlsVX-Hel        NNNNNNNNGCAACATCTTCATAAACTGCGAGACAACACCNNNNNNNNNNNNNNNNNNNNN 4200 
AlsVX-Jap        CCAACCCCAAAACATCTTCATAAACTGCGAGACCACGCCGGATCACCTAAATGAATTTAT 4200 
                         ..***********************.**.**.. .    .   ..  ... . 
 
AlsVX-Hel        NNNNAGCCAGAGGTCTTTCACASAGCCTGCCCACACCAACGATTTCACTGCCTTCGACCA 4260 
AlsVX-Jap        CAAAAGCCAGTGGTCTTTCACACAACCCGCCCACACCAACGATTTCACCGCCTTTGACCA 4260 
                     ******:***********.*.** ******************** ***** ***** 
 
AlsVX-Hel        AANNNNNGATGGTGCCATGCTACAGTTTNNNNNNCTAAAAGCCAAATTCTTCAACGTACC 4320 
AlsVX-Jap        AACTCAGGATGGCGCCATGCTACAATTTGAGGTTCTCAAAGCGAAATTCTTCAACGTTCC 4320 
                 ** .  .***** ***********.***. ....**.***** **************:** 
 
AlsVX-Hel        TCCCGAGATCATCGAAGGATACATCTACATCAANNNNNNNNNNNNNNNNNNNNNNNNNNN 4380 
AlsVX-Jap        GCCCGAAATCATCGAAGGCTACATATACATCAAACTCAACGCGGAAATCTTCCTAGGCAC 4380 






AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4440 
AlsVX-Jap        CCTCGGGATCATGAGACTCAGCGGTGAAGGCCCAACTTTCGACGCTAACACGGAATGCAG 4440 
                   . ... .  .. .  .  . ....  ..      ... .  . .     ..  ..  . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACAAGTGTACGCCGG 4500 
AlsVX-Jap        CATCGCCTACAACGCAACACGATTTTTCGTAGACGACTCAGTCGCACAAGTCTACGCCGG 4500 
                   . .  .     .      . ..... .. .  .  .  .. . ****** ******** 
 
AlsVX-Hel        CGACGACATGGCTTTAGANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4560 
AlsVX-Jap        CGATGACATGGCATTAGATCGCGTGGTGCAGGAGAAACCTAGCTTCAAAAGGCTGGAACA 4560 
                 *** ********:*****. . ......  .. .     . . ..     .. ...     
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4620 
AlsVX-Jap        TCAGCTCAAGCTCACATCCAAACCGCAATACCCAAGCCAAACAAAAGGTGACTACGCCGA 4620 
                 .  . .   . .    .       .   .      .          ....  .  .  .  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTCAAGATGCAGGC 4680 
AlsVX-Jap        ATTCTGCGGGTGGATATTCACACCTAGCGGCATCATGAAGCATAGTCTCAAAATGCAGGC 4680 
                  .. .. ...... . ..      . . ..  .  ..  .  . .. ****.******** 
 
AlsVX-Hel        CTCAATCCAACTCCAGAAGAAGATCAACAACATTGCCCAATCCGCNNNNNNNNNNNNNNN 4740 
AlsVX-Jap        CTCCATCCAGCTCCAAAAGAAAATCAACAACATCGCCCAATCAGCTCGTTCATACGCACT 4740 
                 ***.*****.*****.*****.*********** ********.**. ...  .  .   . 
 
AlsVX-Hel        NNNNNNNNNNNNNGCCTACGACATGGGTGACGCGCTACAAGATCANNNNNNNNNNNNNNN 4800 
AlsVX-Jap        GGATCTGAAGTACGCTTACGACATGGGTGACGCACTACAAGACCATCTAACTGAAGCTGA 4800 
                 .. . ..  ..  ** *****************.******** **. .   ..  . ..  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNCAATCCGTCCGAGACATGCACCTACTCCACCAGAATGANNNNNN 4860 
AlsVX-Jap        GTGTGAACTGCACGCTCAATCGGTCCGCGACATGCACCTACTCCACCAACATGACGTCCT 4860 
                 .....   ..   . .***** *****.********************..**** ..  . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4920 
AlsVX-Jap        AGTCAACGGTGCTTCAAGCCCCCCCCATCCGACCCAAACAACGTCAGCCGCTGACATCCC 4920 
                  ..    .... ..   .         .  .           ..  .  . ..   .    
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4980 
AlsVX-Jap        CACTGGTAGCGCCAAGACTAAGAAAAGAAACCTATCCAAAAGGAAAGCTAAAGTAGCCAA 4980 
                    .... . .    .  .  .    .     . .      ..   . .   .. .     
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5040 
AlsVX-Jap        AATCGACAGTAGCGGAGATTTCAATTTCCGTTGCCCCAGTTCCCCCCCACGCCAATAGGA 5040 
                   . .   .. . .. . ...   ...  ....     ...         .    . ..  
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNA 5100 
AlsVX-Jap        GCCGGGTTAAGTGTCCTGATTGTGAAATGGCTTTGTTCTACCTCCAAACTTTATTACTCA 5100 
                 .  .....  ....  .. .....   ... ...... .   .      ... ..  . * 
 
AlsVX-Hel        ACAGCGATTTCACCCGGACCANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5160 
AlsVX-Jap        ACAGTGATTTCACCAGGACCACAACCCCCACAGCTAGCCCCCTCATCATCTTTGGTACTG 5160 
                 **** *********.******           . . .     .  .  . ......  .. 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNCAATAATCCGCGCCCTAGCTTNNNNNNNNNNNNNNNNNNNCT 5220 
AlsVX-Jap        CTGGCTGTGGCAAAACCTCAATAATCCGCGCTCTCGCTTCCCAATTCCCCGAACTCCACT 5220 
                  ... .....       .************* **.****     ..    .   .   ** 
 
AlsVX-Hel        TCTCYAGCTTCCACCCCATCGTTCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5280 
AlsVX-Jap        TCTCTAGCTTTCACCCCATCGTGCTCCTACCCAACATCCGTAAGAAACAGCACCTAGCCA 5280 
                 **** ***** *********** *.  .        .  ..  .     .    . .    
 
AlsVX-Hel        NNNNNNNNNNNNNNACCGACGTGTTAGACGAATTCCTCGCAGGCCCCAACNNNNNNNNNN 5340 
AlsVX-Jap        ACCCCAACGAAGCCACTGACGTGTTGGACGAATTCCTTGCTGGCCCCAACCCCGAAGTCC 5340 
                         .  .  ** ********.*********** **:*********   .  ..   
 
AlsVX-Hel        NNCTAGCCAAATTCTGTGACCCCNNNNNNNNNNNNNNNNNNNNNNNNCCCGAACCACACT 5400 
AlsVX-Jap        GAATAGCCAAATTCTGCGACCCCCTTCAATACAACTGTGAGACCTTGCCAGAACCCCACT 5400 
                 . .************* ****** ..   .     .... .   ...**.*****.**** 
 
AlsVX-Hel        TCATAAGTGAAACCACTTACCGATTCTGCCCACGTACCTGCGAACNNNNNNNNNNNNNNN 5460 
AlsVX-Jap        TCATAAGTGAAACCACCTACCGCTTCTGCCCACGCACCTGTGAACTACTCAACGACATCT 5460 
                 **************** *****.*********** ***** ****.  .    .   . . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5520 
AlsVX-Jap        TCAAAACAACTCTCAAGAGCAAGGTTCTAGAGATTTGCAAAGTTGCGTGCGTCGACCCAT 5520 






AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5580 
AlsVX-Jap        ACGCAGTAGACCCCGTCGGTAAAGTGATCGCTATCGAACAAGAGTTATTCCCAATTCTAA 5580 
                   .  .. .     .. ...   ... . . . . .     . ... ..     .. .   
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5640 
AlsVX-Jap        GCGCACACGGCCTGACCGTACACTCACCCGATTTCCTCACCGGTCAAACCATACCTGAAG 5640 
                 . .     ..  ..   ..    .     . ...  .    ...       .   ..  . 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACCTCCTCTTCA 5700 
AlsVX-Jap        TTTCAGTGTACACACTCAATCTCAAGCGGGCCGTAGCTGAGCATCCTCACCTCCTCTTCA 5700 
                 ...  ....      .   . .   . ...  .. . .. .  .  . ************ 
 
AlsVX-Hel        TAGCCATCACACGCCACAGCAAAACCCTCTACCTNNNNNNNNNNNATGCCGGGTCTGACT 5760 
AlsVX-Jap        TCGCCCTCACCCGCCACAGCAAAACACTCCACCTCTTCGACCTCAATGCCGGGCCTGACA 5760 
                 *.***.****.**************.*** **** .. .   .  ******** *****: 
 
AlsVX-Hel        CCACCGCCTAACTACGAAAACGTCTACAAGCTNNNNNNNNNNNGCTTCATTTGCGTTGGC 5820 
AlsVX-Jap        CCACCGCCTAACTACGAAAACGTGTACAAACTGGTGGCACTAGGCTTCATCTGCGTCGGC 5820 
                 *********************** *****.**.....   . .******* ***** *** 
 
AlsVX-Hel        ATCATCCTAGCTANNNNNNCAAACCACAATCACCACACCGGCGACCAACAACATTCTCTA 5880 
AlsVX-Jap        ATCATCCTCGCTACCAAATCCAACCACAACCACCACACCGGCGACCAGCAACATTCACTA 5880 
                 ********.****     .*.******** *****************.********:*** 
 
AlsVX-Hel        CCATTCGGCGGCCTGTACNNNNNNNNNNNNNNNNNNNTTTCTTACTTCCGCCCTTCTGAC 5940 
AlsVX-Jap        CCATTCGGCGGCATTTACAGGGATGGCACCAAAACTGTCTCTTACTTTCGCCCTTCTGAC 5940 
                 ************.* *** ... ...         ..* ******** ************ 
 
AlsVX-Hel        CCTATCACCCACTCAAATAAATGGCTGGCCTTCTCATCAGTCCTCACCATCAGCCTCATC 6000 
AlsVX-Jap        CCTATCACCCACTCTAATAAATGGCTGGCCTTCTCATCAGTCATCACCATCAGCCTCATC 6000 
                 **************:***************************.***************** 
 
AlsVX-Hel        ATTTGGCTTTGCTCTAAATTTTCTCCTGGTGATCGGCGGCCTCTACCTCCTGTATGTACT 6060 
AlsVX-Jap        ATTTGGCTATGTTCTAAATTTTCTCCTGGTGATAGGCGGCCTCTACCTCCTGTATGCTCT 6060 
                 ********:** *********************.********************** :** 
 
AlsVX-Hel        CACTGCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGGAGAAAGTGTGACAAT 6120 
AlsVX-Jap        CACTGCACCTCCCACTAAGGCCGGTTGCATCGTACGCGTGACGGGCGAAAGTGTGACCAT 6120 
                 ******   .     .  ..  .....  . ..  . ...  .**.***********.** 
 
AlsVX-Hel        AGATAATTGCCCGGACACGGCCNNNNNNNNNNNNNNNTTTAACCTCGCTCCTTGGAACGG 6180 
AlsVX-Jap        AGATAATTGCCCGGACACAGCTTTAATAATGGAAAAATTCAATCTCGCTCCTTGGAACGG 6180 
                 ******************.** ..  .  ...     ** ** ***************** 
 
AlsVX-Hel        GGTTAAGTTTCCAAAAGATTGAAAATTTTACNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6240 
AlsVX-Jap        GGTTAAGTTTCCAAAAGAATGAAAATTTTAATTATAAACCAGACACCTTTCTTAATTAAA 6240 
                 ******************:***********... .      .     ... ..  ..    
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTGCCGACC 6300 
AlsVX-Jap        TGGCAGGAGAAAACACACCACCCACCCCCCCGACAGCACCAGCCGGCTCCGCTGCCGACC 6300 
                 ...  .. .                      .   .     .  .. .  . ******** 
 
AlsVX-Hel        TCGCCAACCCCAACCGCAGCCCCACCGNNNNNNNNNNNNNNNAACTCAAGTACCAATCGA 6360 
AlsVX-Jap        TGGCTAACCCCAACCGCAGCCCCACAGTTTCCGACCTAGCTAAACTCAACTACCAATCGA 6360 
                 * ** ********************.*...  .   . . . ******* ********** 
 
AlsVX-Hel        CTACCACATCAGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCG 6420 
AlsVX-Jap        CCACCACCTCAGTCGCCACCCCAGAGGAGATCACTGCCCTTGGTGTGCTCTTCACTAGCG 6420 
                 * *****.***** .        . .. . .   ..   ........ . ..   . .** 
 
AlsVX-Hel        CCGGCGTCGACCCCAACTCTGTTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCTG 6480 
AlsVX-Jap        CCGGCGTAGACCCCAACTCAGTTCCACTGGCCATGTGGGATTTAGCTCGGGCCTATGCTG 6480 
                 *******.***********:***    ...   ...... ... . . ...  . .**** 
 
AlsVX-Hel        ACGTCCAGTCAAGCCGCAGTGCTATGCTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6540 
AlsVX-Jap        ACGTTCAGTCCAGCCGCAGTGCCATGCTAGTGGGGTCCACTCCATCCAACAAATCCATCA 6540 
                 **** *****.*********** ***** .......    .   .        .   .   
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCCCGCCAGTTCTGCA 6600 
AlsVX-Jap        CCCGTCAGACCCTTGCCCGCAAGCTGGATCAAGTCAACATCACGCCACGCCAATTCTGCA 6600 
                    ..  .    ...   .   . ... .   ..     .   .**.*****.******* 
 
AlsVX-Hel        TGTACTTCGCTAAGGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6660 
AlsVX-Jap        TGTACTTCGCAAAAGTCGTGTGGAATATCCTGATCAGCAGCAACACCGCACCCGCCGGCT 6660 






AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCTGCTTTCGATTTCTTCGACGGCG 6720 
AlsVX-Jap        GGGCAAAGTTGGGGTACCCCGAAGAATGCAAGTTCGCTGCATTCGACTTCTTCGACGGTG 6720 
                 ...    ........     .  .  ..   ... *****:***** *********** * 
 
AlsVX-Hel        TCCTATCCCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6780 
AlsVX-Jap        TCCTCTCCCCAGCCGCACTTGATCCCGCTGACGGGCTCATCAGACAACCCAACACCCGGG 6780 
                 ****.****  .  .   ... .   . ..  ... .  .  .              ... 
 
AlsVX-Hel        NNNNNNNNNNNNNNNNNNNNNNNNNNNNTGGAGCTCTAGCTCGCCAACGCATCAGCAATG 6840 
AlsVX-Jap        AGATCCAAGCCCACTCAACGGCTAAGTTTGGAGCTCTCGCCCGCCAACGCATCAGCAATG 6840 
                  . .    .     .    .. .  ...*********.** ******************* 
 
AlsVX-Hel        GCAACTANNNNNNNACTCTTGCCGAAGTCACCCACGGCAGAGTTGGTGGGGTCAATGCCA 6900 
AlsVX-Jap        GCAATTTCGTCTCAACACTCGCCGAGGTCACCCACGGCAGAGTCGGAGGTGTCAATGCCA 6900 
                 **** *: .. .  **:** *****.***************** **:** ********** 
 
AlsVX-Hel        TGTACTCCATCGAAGCCCCCCCAGAAGCCTAAGCCTTTCTCCTTGCCCAACTTAAATAAG 6960 
AlsVX-Jap        TGTACTCCATCGAAGCCCCCCCAGAAGCCTAAGCCTTTCTCCTTGCCCAACTTAAATAAG 6960 
                 ************************************************************ 
 
AlsVX-Hel        GAGGTGTTTTTCTACAGTTTGTTTTTNNNNNNNNNNNNNNNNNNNNNNN 7009 
AlsVX-Jap        GAGGTGTTTTTCTACAGTTTTATTTTCACTAATATACTATGTGTGTGTT 7009 







MAQ-RECOVERED GENOMIC SEQUENCE OF FMV-Hel 
FMV RNA1-RdRp gene 
                                                                                          ?ORF1 start   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 60 
FMV-Can01        TGAACTCCCTTTAATTAAACAAAAAATCAAAAATATCCAATGGAAGCTAAAAAAGGTGAA 60 
                 ..   .   ...  ..          .      . .    ...  . .      ....   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 120 
FMV-Can01        ATATTCGAGAGTGCGATCAGCAAAATAAGATCTGGAGATGCATTACCACCTGATCTCATG 120 
                  . .. . . ... . .  .     .  . . ... . ..  ..      .. . .  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACACAATCACATCAAAGAAA 180 
FMV-Can01        AGTAAGTTCTTGCACATAGCTGGTAAGACACTGAAGGGTTACACAATCACATCTAAAAAA 180 
                  ..  ... ...    . . ....  .    ..  .....*************:**.*** 
 
FMV-Hel          AGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTGATGCTGACTTCCATAAAGATCNN 240 
FMV-Can01        AGGAACATTGAAAAGATCTATAAGCAGTGTACTAGTGATGTTCACTTCCATAAAGATCTT 240 
                 ***    ...    . . . .  .  ....  . .***** * ***************.. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 300 
FMV-Can01        GTATCACTTTCAGAAGGAATATTACACACACCACCTAATCAAAGCCAAATTGATATAGTT 300 
                 .. .   ...  .  ..  . ..            .  .    .     ... . . ... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 360 
FMV-Can01        GCCACTTTAATTGGTTTACTTGAGTTATCTAGGCATGATCTGCTGATCTTATGCATCAAT 360 
                 .    ...  .......  ... ... . . ..  .. . .. .. . .. ..  .   . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 420 
FMV-Can01        GAATTGTTGCAGAATCAAGGTTATACCATCATGGGCTATGATGTACCAATCAAAGATGTG 420 
                 .  ......  .  .   .... .    .  .... . .. ...     .    . .... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 480 
FMV-Can01        TTCCCTGAAATTGATAGCATCTTAACACCTGATATATTCTTTACAGATGGTTACGATTAT 480 
                 ..   ..   ... . .  . ..      .. . . .. ...   . .....  . .. . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 540 
FMV-Can01        TATATATTAGAAGTTAAAGTCAGAGGAAAGAAGACTGACTTGTCTATTTATTATAATAGA 540 
                 . . . .. .  ...   ..  . ..   .  .  ..  .... . ... .. .  . .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 600 
FMV-Can01        TATAAATCAGTTGTTGATGGTTCACAAAAGCACATTAAAGTTAGTGTTTTCAATGTTTCA 600 
                 . .   .  ....... .....       .    ..   ... .......   .....   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 660 
FMV-Can01        AGGTCTGGTTACATTGAGATGGGTGATTACAAGATCTCAAATCTTATTAATATTGATCCA 660 
                  ... .....   ... . ...... ..    . . .    . .. ..  . ... .    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 720 
FMV-Can01        TCTACCATTGAAGATATTACATATTGTATAGACTTGTGCCAGAACCTAAGAGAAAAGTAT 720 
                 . .    ...  . . ..   . .... . .  .....   .    .  . .    .. . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 780 
FMV-Can01        GGTAGGTATCCTGAATTTGGATTTTATATGCAAGATGGTATGCTTGCTGATAGCAGTGAA 780 
                 ... ... .  ..  ..... .... . ..   . .... .. ... .. . .  ...   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 840 
FMV-Can01        CCATTTATTGAATCTGGTTTTAAACAGATGGTTTTTGAACATGACAATTATGAAGAGATC 840 
                    ... ...  . .......     . .........    ..    .. ..  . . .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 900 
FMV-Can01        TCAAGCCTATTTGGTAGCAAATGGAATGAAATTATAAATGACACTGATAATATAAGCTTG 900 
                 .   .  . ...... .    ...  ..   .. .   ..    .. .  . .  . ... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGTTATACCAA 960 
FMV-Can01        ATATCCAACCCTGAAGATACTATTGAGAAGTTATTAGATGCTCAAAAGGTGTTATATCAA 960 





FMV-Hel          GATTGTTCTGATANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1020 
FMV-Can01        GATTGTTCAGATAGATATATTGAATTCCAGTCTCATTTAGAAAAAAATTATATGAGTACT 1020 
                 ********:****. . . ...  ..   .. .  ... .       .. . .. ..  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1080 
FMV-Can01        AATTCTTACAATAAGACATATCTAAATGATTGCAATTTATCAAAAATATTAGATAAAAAG 1080 
                   .. ..    .  .   . . .   .. ...   ... .      . .. . .     . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1140 
FMV-Can01        AATGAATCTTTATATAACATTGTCGACACATATAAACCATCTATTTACATACCAATTGCA 1140 
                   ..  . ... . .    .... .     . .      . . ...   .     ...   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1200 
FMV-Can01        AAAACAGTATTCCTTGATAAATTTGGGTTTTCAAGATTAGATTTTTATAAATCAGCATTT 1200 
                       .. ..  ... .   ..........   . .. . ..... .   .  .  ... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1260 
FMV-Can01        ATAGATATTCAAGAGAGAGGAGACTCTTACACCAAATCTGTCATCAATCTGGTTAATACG 1260 
                  . . . ..   . . . .. .  . ..        . ...  .   . .....  .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNGATTTATTTGTTAAAAAAAATTNNNNNNNNNNNNNNNNN 1320 
FMV-Can01        ATATTTAATAGCGTCTCAATTGATTTACTTGTTAAAAAAAATGATGAGATTGATCTAGAA 1320 
                  . ...  . . .. .   ..****** **************  .. . ... . . .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1380 
FMV-Can01        ACCTACAAAGATGTTCTAACGCCTGATTTCTGTAAATACATAAATGATACAAGCAATAAG 1380 
                    .     . .... .   .  .. ... ...   .   .   .. .    .   .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1440 
FMV-Can01        TTCAAGAAAATTGCAACAGTATCTAACATAACAAGTGATACAAGCATTTTGAATAATAAT 1440 
                 ..   .    ...     .. . .    .     ... .    .  .....  .  .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1500 
FMV-Can01        GCATTTTCAATTAACCATCATGTGGATAAATATATGAAAGAAAATATTTGTGGATTTCAG 1500 
                 .  ....   ..     .  ..... .   . . ..   .    . ....... ...  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1560 
FMV-Can01        AATAAACATTATGATGTAGATGTCCAAAAAAAGAGCTGCCTATCAATAAAAAATAGTGAA 1560 
                   .     .. .. ... . ...         . . ..  . .   .      . ...   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1620 
FMV-Can01        GATGATGCATTAGAACTATTAAAGTTAATGGGGGAGATATTTAATAGTAAGCATTATGAA 1620 
                 . .. ..  .. .   . ..   ...  ...... . . ...  . ..  .  .. ..   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1680 
FMV-Can01        GGGGTATATGCAAATGATCTAGTAGATATTGAGGTTGATAATATGAATAGTCATGTATGC 1680 
                 ..... . ..    .. . . .. . . ... ..... .  . ..  . ..  ... ..  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNAAACTAAATATCTAGATCACCTNNNNNNNNNNNNNNNNNNN 1740 
FMV-Can01        AATCTTCCAAAAAATTGCAAAACTAAATATTTAGATCATCTTTACAGCCAGCATAATATA 1740 
                   . ..        ...  *********** ******* **..   .   .  .  . .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNATTCAGATTGATCCAAACA 1800 
FMV-Can01        TTCAAAGCTTTAATATCATTGAACACAGTTAATTCTCATAAATTTAGATTGATTCAAACA 1800 
                 ..    . ...  . .  ...      ...  .. .  .  *** ******** ****** 
 
FMV-Hel          GCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1860 
FMV-Can01        GCAGATCCATGTACAATATTAATCATGCTTCCAAACGCAGACACCCTGAAATCTGCACCA 1860 
                 ** . .   ...    . ..  .  .. ..      .  .      ..   . ..      
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1920 
FMV-Can01        CTTAGGTATTTCACACTTACAATAATTGATAAAAAGGATAATACAAGTTACCATGCAAAC 1920 
                  .. ... ...     ..    .  ... .     .. .  .    ...    ..      
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1980 
FMV-Can01        AAGCTATTGGGAATAGCACATGAGTTATTAGTCGGTCGGAATTATAATATAATATTATCT 1980 
                   . . .....  . .    .. ... .. .. ... ..  .. .  . .  . .. . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTCATTCATTTGCAAAATAT 2040 
FMV-Can01        AAAGTTGTAAGTTTAGATGTTACAAGACTTAAGCTATTAAATCATTCATTTGGCAAATAT 2040 
                    .....  .... . ....    .  ..  . . ..   *********** .****** 
 
FMV-Hel          TGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2100 
FMV-Can01        TGTTTAATTATGTCTTATTATTCAACCATAAAGAAAGATTTAAGACATCAAATCCATTTT 2100 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNCCATATCATCACTGAGCATAACTGATACATAT 2160 
FMV-Can01        ATGGTGTGGATATTATGTCAATTTATTACTATATCATCACTAAGCATAACTGACACCTAT 2160 
                  ........ . .. ...   ... .. * ***********.*********** **.*** 
 
FMV-Hel          AAGAATTTTATAATGGCTATATATTCAGATTACTCAAATATTGANNNNNNNNNNNNNNNN 2220 
FMV-Can01        AAGAATTTTGTCATGGCTATATATTCTGATTATTCAAATATTGACAATCTGATTGATGAC 2220 
                 *********.*.**************:***** ***********   . .. ... ..   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2280 
FMV-Can01        AAGTTAGAGTCTAGGCCTACAACATTAGGGCATATAGTAATCTTACAAAGGTGTTTCCAT 2280 
                   ... . .. . ..  .      .. ...  . . ..  . ..     .......   . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2340 
FMV-Can01        GGTCTACTCCAGGCTTCTACACAACTCAAGGTAATTAACAAAAACAAAAACAGCGAAGAG 2340 
                 ... .  .   .. .. .       .   ...  ..                . .  . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2400 
FMV-Can01        ATTGATGAGAGGGGTGATTTAATCGAAACTGGATTTAATAGCAACTTATCATTAAAGCTG 2400 
                  ... .. . ...... ...  . .    ... ...  . .    .. .  ..   . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2460 
FMV-Can01        CCAATATCAGGTATTAGTGTCAATAATCCTAGGGAGATTATACATGAAGCATTTATGTTA 2460 
                     . .  ... .. ....   .  .  . ... . .. .   ..  .  ... ....  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2520 
FMV-Can01        TTTTATCTAGGTAATAAAGGCCTTCATGGTTCTCCACAGGAGTTGTTAAACTTGTATTAC 2520 
                 .... . . ...  .   ..  ..  ..... .     .. ......    .... ..   
 
FMV-Hel          NNNNNNNNNNNNTTCGAAAAAGAATATACTGATNNNNNNNNNNNNNNNNNNNNNNNNNNN 2580 
FMV-Can01        ACACCATACAAATTTGAACAAGAATATACTGATGTAATACAGAGATATAAAACTATTTTA 2580 
                       .     ** ***.**************..  .   . . . .     . ....  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2640 
FMV-Can01        CAAGAGGATGGAAATATTTCTAATATGTCAATCTCATATGATGTTATGAAAAAAACATCA 2640 
                    . .. ...   . ... .  . ...   . .  . .. .... ..         .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2700 
FMV-Can01        TTAGCAGCTTATTCAAATATTTATAATAAAAAAGAAAACATAAGGCAATCTATATGCAGT 2700 
                 .. .  . .. ..    . ... .  .      .      .  ..   . . . ..  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2760 
FMV-Can01        GAATTAAGTATTAATAAGCCATTACTAGCATTGAAACAATTCTCTAGTACAAAATCTATG 2760 
                 .  ..  .. ..  .  .   ..  . .  ...      .. . . ..      . . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2820 
FMV-Can01        GTGTCTAACACAAAGCAGGTCGAAATAGAATTACCAAAAAAATTACCTGATAATCTAGAT 2820 
                 .... .        .  ... .   . .  ..          ..   .. .  . . . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2880 
FMV-Can01        CTATATGGGTTAGAGAATATCATATCGAATTGCAAGATTGATGAAGATATGGAGTTCATG 2880 
                  . . ...... . .  . .  . . .  ...   . ... ..  . . ... ...  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2940 
FMV-Can01        AGATTTATAAATTCAGAAATTTACAGAATTAATTCAAAGAGATTAAAAAATGAAATGAGT 2940 
                  . ... .   ..  .   ...   .  ..  ..    . . ..      ..   .. .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNATATATATAGAGACA 3000 
FMV-Can01        AGTTCCACAAGAGAAGAAAAAAAGGAAGTTACTTTATTACCTGAGATATATATAGAAACA 3000 
                  ...      . .  .       ..  ...  ... ..   .. .***********.*** 
 
FMV-Hel          GAGAAAGGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3060 
FMV-Can01        AAGAAAGGTGTGAAATTTTTAAGGATAAAAAGGCATGAATACACTAGATTGATCAATGGT 3060 
                 .********...   .....  .. .     ..  ..  .    . . ... .   .... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNATGCTAAGGTCTTTGATGAATTNNNNNNNNNNNNNNNNNNN 3120 
FMV-CAN01        GACTATATTAGACAGAACAATGCAAAGGTTTTTGATGAATTTTACAAATTATCTGAAGAG 3120 
                 .  . . .. .   .    ****:***** ***********..     .. . ..  . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTTTAATACATGAGGATGAATTANNN 3180 
FMV-Can01        TATGAGCTCGTCTCACTCAAGGACGCATACTCTAAGTTAATACATGATGATGAATTACTG 3180 
                 . .. . . .. .   .   ..  .  .  . .   *********** ********* .. 
 
FMV-Hel          NNNNNNNNNNNNNNNAAAGACCAAAGAACTGCTGAKGATAGAGAAATNNNNNNNNNNNNN 3240 
FMV-Can01        ATTCGAATATTTTATAAAGATCAGAGAACTGCTGATGACAGAGAAATATATACAGGTAAT 3240 






FMV-Hel          NNNNNNNNNNNACTATGTTTATATCCAATAGAAAAAAAANNNNNNNNNNNNNNNNNNNNN 3300 
FMV-Can01        GCTCAAACTAGACTCTGTTTGTATCCAATAGAAAAAACATATAAGGCAATTTGTAAACAT 3300 
                 . .     . .***.*****.****************.*. .  ..   .....     . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3360 
FMV-Can01        ATCCCAGGTGAAGCAATAACAATCAGCGGTGATCAAAAGCAAAAAAAACTACTGGAGCAA 3360 
                  .    ....  .   .     .  . .... .     .          .  ... .    
 
FMV-Hel          NNNNNNNNTCTGATWAAASAAAAGAAACAAAARATTAGAGANNNNNNNNNNNNNNNNNNN 3420 
FMV-Can01        AGACTACAGCTGATCAAAGAAAAGAAACAAAAAATTAAAGATAAAAAATGGGCTGAAATC 3420 
                  .  .    ***** ***.************* ****.***.      .... ..   .  
 
FMV-Hel          NNNNNNNNNTCATCAGATGCATCCAAATGGTCTGCWAGAGNNNNNNNNNNNNNNNNNNNN 3480 
FMV-Can01        TATTCTGTATCCTCAGATGCATCAAAATGGTCTGCTAGAGATGTGTTCTTAAAATTCATA 3480 
                 . .. ... **.***********.*********** **** ...... ..    ..  .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3540 
FMV-Can01        ATCACAATATCTGTAAATCCATATCTCCACCCTGATGAAAAATGGTTTTTATTATATCTG 3540 
                  .     . . ...   .   . . .      .. ..     ........ .. . . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCAAATAGCATATTCAATAAAATNNNN 3600 
FMV-Can01        TGTATGACCTATTACACCAAAAAAATTGTGTTTACAGATACCATATTCAATAAAATGGTT 3600 
                 ... ..   . ..            ........ **.*** ***************.... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3660 
FMV-Can01        GATCTAGCAGATAAAGATAAACATGGAAAGTATGAGTTTATGACTGAAGACTTTACACAA 3660 
                 . . . .  . .   . .     ...   .. .. .... ..  ..  .  ...       
 
FMV-Hel          NNNNNNNNNNNNNTWAGGAGCAACTGGTTACAAGGCANNNTCAACATGATATCATCATTT 3720 
FMV-CAN01        AACTACTTTACAGTAAGGAGCAATTGGTTACAAGGCAATCTTAATATGATATCATCATTT 3720 
                    .  ...   .* ******** ************* . * ** *************** 
 
FMV-Hel          GTCCACCACTGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3780 
FMV-Can01        GTCCACCATTGCTCCACATTGTACACTGAGACCATGTTAAAGATTTTATCTGATAAAAAT 3780 
                 ******** ** .     ....    .. .    ....   . .... . .. .     . 
 
FMV-Hel          NNNNNNNNNNNNNNNNTGACATCAATGGTACAYTCTGATGATTCAACTTATGATTTCNNN 3840 
FMV-Can01        TCTTTGGAATGCTCTATGACATCTATGGTTCACTCTGATGATTCAACATATGATTTTCTA 3840 
                 . .....  .. . . *******:*****:** **************:********  .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 3900 
FMV-Can01        ATCTGTAGAGATAAAAAATCAAAGAATAGATATGTGAAAGAAGAAAACATTGGCAAACTC 3900 
                  . ... . . .      .    .  . . . ....   .  .      ....     .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTCTAAACGAAAAAAAG 3960 
FMV-Can01        ATTATATCCTTGATTACATACTCAAATAGATTTCATTGTATAACACTAAATGAAAAAAAG 3960 
                  .. . .  ... ..   .  .    . . ...  .... .   :***** ********* 
 
FMV-Hel          ACMTATATTAGCACATTTTATAAAGAGTTTCTTTNNNNNNNNNNNNNNNNCAATGAACTA 4020 
FMV-Can01        ACATATATTAGTACATTCTATAAAGAGTTTCTCTCTACAATTATAGTTGGCAATGAACTA 4020 
                 ** ******** ***** ************** * .    .. . .....********** 
 
FMV-Hel          TTTTTTATTTATTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4080 
FMV-Can01        TTCTTTTTTTATTTAGCTGATTTATTACCATTGACATCAGATACAAGTTATGCCTCACCA 4080 
                 ** ***:******. . .. ... ..    ...   .  . .    ... ..  .      
 
FMV-Hel          NNNNNNNNNNNNNNNTCATACTCTGGTTATATAAACNNNNNNNNNNNNNNNNNNNNNNNN 4140 
FMV-Can01        TTGCAGGATTTAGCATCATATTCTGGTTATATAAATAATTCCTTTTCACATGCTTGCCCA 4140 
                 ...  .. ... .  ***** **************   ..  ....    .. ...     
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4200 
FMV-Can01        AGAGAGATGATCCAAACAGCTATCATACTGATCAATCACTTGACATTATCCACTTATAAC 4200 
                  . . . .. .       . . .  .  .. .   .   ...   .. .    .. .    
 
FMV-Hel          NNGCATTATACATCTGAAAAAAATCCANNNNNNNNNNNNNNNNNNNNNNNNTTAACAATC 4260 
FMV-Can01        ATGCAATATACATCTGATAAAAATCCAAGGTTGAATATACAATCTACTGATTTACCAATC 4260 
                  .***:***********:********* .....  . .    . .  .. .***.***** 
 
FMV-Hel          CAGATAAACCCTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4320 
FMV-Can01        CAGATATACCCTCGTTATAAAGTTCCAATTGAAATGGCTGGTATGATACCCTATTACTCA 4320 
                 ******:***** ... .   ...    ...   ... .... .. .    . ..  .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4380 
FMV-Can01        GCAGATGCATTCAATATCCTGAATGATATAGTATTGAAATTAGGTTACAATGACAAATTG 4380 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4440 
FMV-Can01        CAGTCAGAGCTCGTGGAGGATATTTTGACTGAAGAACTCATTAGTGATTATCTTAACATA 4440 
                   ..  . . . .... .. . .....  ..  .   .  .. ... .. . ..    .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGCATCTTGTGCATGGAT 4500 
FMV-Can01        ATAAAAAAACATACACCAATGATTGTTAAATATATCAAATCATGTATCTTGTGTATGGAT 4500 
                  .         .       .. .....   . . .    .  .* ******** ****** 
 
FMV-Hel          TACTCTCAATATGAAAGAGATGATGCTGACCCNNNNNNCATAATAGAYTATGATTTRAGY 4560 
FMV-Can01        TACTCACAGTATGAAAGAGATGATGCAGATCCATATAATATAATAGATTATGATTTAAGT 4560 
                 *****:**.*****************:** ** . .   ******** ******** **  
 
FMV-Hel          CMAAAATCWWTTATNAATGTGATCAGTCTGAATAAAGGNNNNNNNNNAAAGAAAACTTAT 4620 
FMV-Can01        CAAAAATCTATTATTAATGTCATCAGTCTTAATAAAGGCCAGCGATTAAAGAAAACTTAC 4620 
                 * ******  ****.***** ******** ********   . . ..************  
 
FMV-Hel          ACCTACAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4680 
FMV-Can01        ACATACAAGAAGTATTTAGAATCAGAAACTAATGTACGATTAATATCTGCTATACATCCT 4680 
                 **.*****.  .. ... .  .  .    .  ...  . ..  . . .. . .   .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAAATCAAATATCCTACAAAAT 4740 
FMV-Can01        GAATGGTGTGTGATAAAACCAACTGACCCAGAGTTAATTAAATCAAATATATTACAAAAT 4740 
                 .  ......... .         ..     . ...  ..***********. ******** 
 
FMV-Hel          TATACCAATCCCAATTTCAGAGATGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 4800 
FMV-Can01        TATACAAATCCCAATTTTAGAGATGGATTAATATTTTCCACTCCTGCAATTGATTATGGT 4800 
                 *****.*********** ******** ..  . ....    .  ..   ... .. .... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNGAATATGTATACTGTAAGTTCACATNNNNNNNNNNNN 4860 
FMV-Can01        CGTAGAGTTATTAGTTCAAACAAGAATATGTATACCATAAGTTCACATATTATGGAAAAA 4860 
                  .. . ... .. ...       ************ .*********** .. ...      
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNATCATCAGAATGAGAAAATAGATGNNNNN 4920 
FMV-Can01        GATAAAGCAAAAAATATAAAAACAGTATACAATGATCTAAATGAGAAAATAGATGGAGTT 4920 
                 . .   .       . .       .. .   ** ***:.****************. ... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAGTCTTYACCTGTTAAGTGATAAAAAA 4980 
FMV-Can01        GAAATAACAGCTAAGGATCTACAAAGATATCTAAGCCTTTATCTGTTAAGTGATAAAAAA 4980 
                 .   .    . .  .. . .     . . . . ** *** * ****************** 
 
FMV-Hel          ATCTCCATGGCTGTACAAGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5040 
FMV-Can01        ATCTCTATGGCTATACAAGTATTTTTCTCTAAAATAGAAACAGTGACAATGGCCAGGCCA 5040 
                 ***** ******.******* ..... . .    . .     ...    ...   ..    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNCCTAGAAGCATATATTCTGAAGATTTTGGTAAATANNNN 5100 
FMV-Can01        TCATATAATAAGGTTGTACAACCAAGAAGCATATATTCTGAAGATTTTGGTAGGTACTCT 5100 
                 .  . .  .  ......    **:****************************..** . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5160 
FMV-Can01        AATAACTCATTGATAGAATCTCTTTTAACTTCAAGATATTGTAAAATAGCTACAGTTGAT 5160 
                   .   .  ... . .  . . ....   ..   . . ....    . . .   .... . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5220 
FMV-Can01        CCAAAAGTTGAAAAGTTTGTTGATGTTAGTGATTATGTTTTAGAAAGAATTGGTGATATC 5220 
                       ....    ........ .... ... .. ...... .   .  ...... . .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5280 
FMV-Can01        AAACTATATGAATCACCAGAAGACATTGATGATGACTACATCAATTATTACCAATTTAAA 5280 
                     . . ..  .     .  .   ... .. ..  .   .   .. ..     ...    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5340 
FMV-Can01        TATCCTCATTCTGATGAGGTTATGTTAGATGTTGAGCCTGTTTCTGATCTAGGTGATCTT 5340 
                 . .  .  .. .. .. .... .... . ..... .  ..... .. . . .... . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5400 
FMV-Can01        GAACTCAAAGTTTACAAAAACAAGTTGAAGTTCATGTCATTGCTTGTAAAGTACTATAAT 5400 
                 .   .    ....          ....  ...  ...  ... ....   ..  . .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5460 
FMV-Can01        GATATTAAAAAAACTATTGAAAATCCCAATTACAATATTCCCAATTACCCATCTCCATCT 5460 
                 . . ..        . ...    .     ..    . ..     ..     . .   . . 
 
FMV-Hel          NNNATAATAATGACGATAGACTCATTGCNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5520 
FMV-Can01        TCTATAATAATGACAATAGATTCATTGCTAAAAAAAGATGAGATCAGTACTAAAGTATAC 5520 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNATGATGATTACCTGTTGACTAGATTTGGGATGTAT 5580 
FMV-Can01        TTATCAAATGTAAAATCTATTAAGTATGATGATTATTTGTTGACTAGATATGGTATGTAT 5580 
                 .. .    ...    . . ..  ..**********  ************:*** ****** 
 
FMV-Hel          GCNNNNNNNNNNNNNNNNNCAAAGTACAAGTTAGGCTACAAAGTAAAAATCGNNNNNNNN 5640 
FMV-Can01        GCCCATAATGATTTTCACATTAAGTACAAGTTAGGCTACAAAGTTAAAATTGCATCTAGT 5640 
                 **   .  .. ....     :***********************:***** *  . . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNCAWACATAYAAAGACACATATGANNNNNNNNNNNNNNNN 5700 
FMV-Can01        ACAAAGATATCACACACATTACAAACATATAAAGATACATATGAACCAGTAGCATTTGTC 5700 
                      . . .        .. ** ***** ***** ********    .. .  .....  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5760 
FMV-Can01        ACCAAACTAATATCTAGAAATCTGGAATTATTTACTTCACTTAAAGACAATGAAGATTTT 5760 
                        .  . . . .   . ...  .. ...  ..   ..   .    ..  . .... 
 
FMV-Hel          NNNNCTGGACATCATAAATTTAATGACATGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5820 
FMV-Can01        GTCACAGGACATTATAAATTTAATGATATGATAAACACACTTCAGAATAGTCGAGATATC 5820 
                 ..  *:****** ************* *** .        ..  .  . .. . . . .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5880 
FMV-Can01        AATAGCAGTGCATTATTATTAATGTTGGATAAAATACCAAATTCGAGATTCATGATTACA 5880 
                   . .  ...  .. .. ..  ...... .    .      .. . . ..  .. ..    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 5940 
FMV-Can01        CTACTTAACGATAATAGGGTTTATAATCACTGGCTGATACCAACAAATAGTTTACAAGAA 5940 
                  .  ..   . .  . ...... .  .   ... .. .         . ....    .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6000 
FMV-Can01        GACCCTGGCGCCTCTTTAGCTTATTACATGTGTCAGGGTAATATAATGAAAGTTAGAACC 6000 
                 .    ... .  . ... . .. ..   .....  ....  . .  ..   ... .     
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6060 
FMV-Can01        TTTACCAGAGGTGGTTCCATAGTATTCACAATGACTTACTACAAGTATGTAAACCGAGAC 6060 
                 ...    . .......   . .. ..     ..  ..  .    .. ...     . .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6120 
FMV-Can01        CTTGGTGCACTTGTCAATATTAAAAAGAAGATATCAATGGATTATGTTGAATTATTGAGG 6120 
                  ......   ....   . ..     .  . . .   ... .. .....  .. ... .. 
 
FMV-Hel          NNNNNNNNGGTCACAAATAGAGTTGAACCANNNNNNNNNNNNNNNNNNNNNNNNNTTAAT 6180 
FMV-Can01        AAATCTTTAGTCACAAATAGAGTTGAACCAACATCTTCGTATGACACTTATAATATAAAT 6180 
                    . ....*********************   . .. .. ..    .. .  . *:*** 
 
FMV-Hel          GAATATGGTAGATACACWGAATACAATGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6240 
FMV-Can01        GAATATGGTAGGTACACTGAATACAAAGGTCCAAGGGTATTTAATGTTGCACAGATCAAT 6240 
                 ***********.***** ********:**.    .... ...  .....    . .   . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6300 
FMV-Can01        TATGCCAAAATATTAGACATTAAACCAGCCTATACTGAAATTGATGATCAAGTGAAGCTT 6300 
                 . ..      . .. .   ..      .  . .  ..   ... .. .   ...  . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACWTAT 6360 
FMV-Can01        GTTTTGAATATTGGAACCAATGAAGATCACTTCACATTTGATATACGTTTACGTACATAT 6360 
                 ......  . ....      ..  . .   ..    .... . .  ....  ..** *** 
 
FMV-Hel          ATTGATGAWGAGTATTANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6420 
FMV-Can01        ATTGATGATGAGTATTATTTGAATTGTTTGCTAGATAATTTACACATAGAGCGGGAAAAT 6420 
                 ******** ********....  ....... . . .  ...     . . . ...    . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6480 
FMV-Can01        ATTCTGGGCTATCTATGTGAAGGTACATTTTTTCATAGGTACCCTGATTATCTTAAGCGA 6480 
                  .. .... . . . ....  ...   ......  . ...    .. .. . ..  . .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6540 
FMV-Can01        ATTCTTGCTACACTTGGACCAAATCAACTTGTATCTTTGATGTCTAATTATACTGATTCA 6540 
                  .. ... .    ....      .    .... . .... ... .  .. .  .. ..   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6600 
FMV-Can01        GATTGTATAACTGATAACATAGATGTGAATCGATATGGGTTCCTGATGGAGATTAGCAAT 6600 
                 . .... .   .. .    . . ....  . . . ......  .. ... . .. .   . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6660 
FMV-Can01        TACTTCAGAGATAAAAATAATATATATATGGCAGAATTGTGTGAGACATTAGAGATTGTA 6660 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6720 
FMV-Can01        GCAATGAGCACTAATGTGAACATACTAAATGTTAGAAACCCTGAAAAATTTATAAACAAC 6720 
                 .   .. .   .  ....    .  .   .... .      ..     ... .        
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6780 
FMV-Can01        TGCAATAAAATTAAGCTCCATCCATTATGCCATGAATATGTGATACATAAATATCGTGCA 6780 
                 ..   .    ..  . .   .   .. ..   ..  . .... .   .   . . ...   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6840 
FMV-Can01        GATGAAGAAGCACCATATTATAGATTATTTAGATTAGTTATGAAATACAGATACAACAAG 6840 
                 . ..  .  .     . .. . . .. ... . .. ... ..   .   . .       . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6900 
FMV-Can01        AGCCCTGTAGAGAAAATCATCCTATTCATCATCTTGATATTTAGATTTTACATTCATGAA 6900 
                  .   ... . .    .  .  . ..  .  . ... . ... . ....   ..  ..   
                       ?ORF1 end   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 6932 
FMV-Can01        TACATCGATGTTGAAGCTGAGTTTGAATATTG 6932 






FMV RNA2-putative glycoprotein precursor gene 
                                                                                                               ?ORF2 start   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 60 
FMV-Can01        AGTAGTGAACTCCTCTTAAACAAATCAATCTGATAAAAATCTAAAAGCAAATATGATGAG 60 
                  .. ...   .  . ..       .   . .. .     . .    .    . .. .. . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 120 
FMV-Can01        TATTATTAACTCAGTAATAGCGTTACTTATAGTTGCAATCCTGTGCAACACTGTGAAGAA 120 
                 . .. ..   .  ..  . . ...  .. . ....   .  ....      ....  .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 180 
FMV-Can01        TGCAGTCTACATAGAAGAAGAATTATGTGACTGTCAGCCTTCAATATTAAAACTTGGCAA 180 
                 ..  .. .   . .  .  .  .. ....  ...  .  ..   . ..     ....    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 240 
FMV-Can01        AGGGTTTATAGTGTGTTTTAAAGGTTGTGATGTAAAGCCAGTAAACTCTAAGCTCTACAA 240 
                  ...... . .........   ....... ...   .   ..    . .  . . .     
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 300 
FMV-Can01        CACAACTTGCAGTCACATGAAAGAAGTAACAATAACAATGTGCAAAGGTAATCGATATGT 300 
                       ...  ..    ..   .  ..     .     ....    ...  . . . ... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 360 
FMV-Can01        CACATCATTACCTACTGCAACTGTCCATGAAGAATACACAATCACATCAATCATCCATAA 360 
                     .  ..   .  ..    ...   ..  .  .      .    .   .  .   .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 420 
FMV-Can01        GATATGGAAAGTGGTTATCACAATTACAGTTTGGCTGATCTTTATTGTATTAAAGGTCCC 420 
                 . . ...   ...... .     ..   ...... .. . ... .... ..   ...    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGTTCCATGAACTCCAAGCT 480 
FMV-Can01        AATTCTGTGCTTACTATCAGTTGGGAATCAGGTATTCAATGGTTTCATGAAATCCAAGCT 480 
                   .. .... ..  . .  ......  .  ... ..   ..*** ******.******** 
 
FMV-Hel          GANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 540 
FMV-Can01        GAGAGAGTGTGACACATGCAAAACCAAATATTCTGTATCGCATGTTGATTGTCCTACACC 540 
                 **. . .....     ..          . .. ... . .  ..... ....  .      
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 600 
FMV-Can01        AAGTTTCAAGCTAAGGACAGATTATAATCTTTTTTTCTACACTTTCCTCACTGTGTTACT 600 
                   ....   . .  ..   . .. .  . ....... .    ...  .   ......  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 660 
FMV-Can01        CTTTGTGACACTTGCAAAGGCAGATGATAATGAATTCAATTTTTATCATCATGGAAATCA 660 
                  ......    ...    ..  . .. .  ..  ..   ..... .  .  ...   .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 720 
FMV-Can01        GACTGAAGTACAAATCTTAGACAGGGAACATTATAAACAAGACTTCGATGTCCAAGGCTA 720 
                 .  ..  ..     . .. .   ...    .. .      .  .. . ...    .. .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 780 
FMV-Can01        CCTGTACACTGTTACTGTCTTAAATTCGCATCTTGAGATACAAACTATAAATGTTTCTGA 780 
                   ...    ....  ... ..   .. .  . ... . .      . .   ..... ..  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 840 
FMV-Can01        AATATTGATTCCAACAAAGCATATTTTGACACATGAACACTTCAGTTGTGATGGCTCTGA 840 
                   . ... ..        .  . .....     ..     ..  ...... ... . ..  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 900 
FMV-Can01        AGGCTGTAAAAAAGAGTGTCAAGCTAGGACTGGTTCCATGCCTATGTATTACTTAAAAAA 900 
                  .. ...      . ....   . . ..  .....   ..  . ... ..  ..       
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 960 
FMV-Can01        GGCTTATGATGGATTCTCATGTCTTTTTACGAGTGCAACTTTGTGTGGTCTTTGCAAGAG 960 
                 .. .. .. ... .. .  ... .....  . ...    .......... ....   . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1020 
FMV-Can01        TGAAATGAAGACAATAGGCTACAAAGTAACTACAACAAAGGTTTCACCATATATTGATAT 1020 
                 ..   ..  .    . .. .     ..   .        .....     . . ... . . 
 
FMV-Hel          NNNNNNNNNGCATGGCAATAAAACTGATATCATAAAGATAAGAGAATTCTCTAAGTTNNN 1080 
FMV-Can01        TGAAGTTGTTCATGGCAATAAAACTGAAATGATAAAGATAAGAGACTTTTCTAAGTTTAT 1080 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1140 
FMV-Can01        ACATGAACCTTATTATGTAAAACCAATAGAGCCAGTGTGGGTTGAATCTGTAGATATGTT 1140 
                    ..    .. .. ...        . . .   ..........  . ... . . .... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNATGCCRAGTTATGGATGCTT 1200 
FMV-Can01        TGTTACTGGTACAGATGTTTATGTTGGTCAGATTTGTAATATGCCTAGTTATGGTTGCTT 1200 
                 ....  ....   . ..... .......  . .....  .***** ********:***** 
 
FMV-Hel          TGGTCCCAATTATATAAAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1260 
FMV-Can01        TGGTCCAAATTATAAAAAAGATAATAAAACTTTTGTTATAAGTGCACCTAAGGTTAAAGA 1260 
                 ******.*******:****. .  .     ....... .  ...    .  ....   .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCTGTATAGATCCAGGTAATAGTGA 1320 
FMV-Can01        TCCTATGACACATGATCGTGAATTGATATTAGAACACTGTGTTGATCCAGGTAATAGTGA 1320 
                 .  . ..     .. . ...  ... . .. .    ****.*:***************** 
 
FMV-Hel          TATCAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTAATCAGACCATA 1380 
FMV-Can01        CATAAACAGTCTGCAAAAAACTCAATCAATTTACCATGATGGTGTAATTATTAGACCATA 1380 
                  **.**  .. ..        .   .   ...    .. ......  *:** ******** 
 
FMV-Hel          TGAATTTGGATTGTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1440 
FMV-Can01        TGAATTTGGTATGTTATCTATTGGGTTTCCCATAGTGGGCAAGCTGATAGGTAATTTCTG 1440 
                 *********::***. . . ........    . .....   . .. . ...  ... .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNGGTTGTTATGATTGTCAATCAGG 1500 
FMV-Can01        TGAAAAGCCTGCTGATGTTAAAGAAATAGTGGTTAATGGTTGCTTTGATTGTCAATCAGG 1500 
                 ..    .  .. .. ....   .   . ......  .***** *:*************** 
 
FMV-Hel          TATAGARGCTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1560 
FMV-Can01        TTTAGAGGCTAAAATATCATATAAATTAACTGAAAGGTGCGGGAAAATCATATGTTACTT 1560 
                 *:**** ***    . .  . .   ..   ..   .... ...    .  . ....  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1620 
FMV-Can01        TGGTCAAGTGAAGTATGAATATTTTGTAGATCATGACTATAATGACATAAGTATTCATAC 1620 
                 ....   ...  .. ..  . ...... . .  ..  . .  ..   .  .. ..  .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1680 
FMV-Can01        ATGTTATGATAAGAAAAATATCATAATCAAGTGTAATGACTACTCAAACACATTTTCATT 1680 
                  .... .. .  .     . .  .  .   ....  ..  .  .        ....  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNATGGWGTTCATGGTTCWGCTGA 1740 
FMV-Can01        AGATCACAGTAAAGATACAAATTATTATGGTACTAGTAATGAAGTTCATGGTTCAGCTGA 1740 
                  . .    ..   . .     .. .. ....  . .. ***. *********** ***** 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1800 
FMV-Can01        TATGGAATTCAACATGCTGAAACACTTGCCCAATCTATTATTTAATCCTAAAGTTGTTGT 1800 
                 . ...  ..     .. ..      ...     . . .. ...  .  .   ........ 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1860 
FMV-Can01        AACCACTATGTTAATAATAGCTATGACTATTTATATGGCTTATTGTATATCTAAGCAATT 1860 
                       . ....  .  . . . ..  . ... . ... .. .... . . .  .   .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1920 
FMV-Can01        ATATAAGCATTATGTTAAAGTTAAGATGGACAGGATTATAAGGTATCATAAAAAAACAGA 1920 
                  . .  .  .. ....   ...  . ...   .. .. .  ... .  .         .  
           ?ORF2 end   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1980 
FMV-Can01        TACCATCACAGATGAATCAGCAAATGAATTCATTGTAGTGACTGGTTCTGCACAGTAATA 1980 
                 .    .    . ..  .  .    ..  ..  .... ...  ..... ..    ..  .  
 
FMV-Hel          NNNNNNNNNNNNNNNAATTCCCTAAATCCAAATATCNNNNNNNNNNNNNNNNNNNNNNNN 2040 
FMV-Can01        ATATTTACAATATAAAAATCCCTAAATCCAAATTTCTTTCTAAAGCTTTTTTTTATTTCT 2040 
                  . ...    . .  **:***************:**... .   . ........ ... . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2100 
FMV-Can01        GATGCGTTGCATCACTCATCCAGCAAGCTGTATGGCTATACATGGTGAAAAGCCTGCAAG 2100 
                 . .. ....  .   .  .   .   . ... ... . .   .....    .  ..   . 
 
FMV-Hel          NNNNNNNNNNNCTCTCAAGGTTGATGCATATGNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2160 
FMV-Can01        TTGGTCTATGCCTCTCAAGATTGACGCATATGTACCCATTGTATGCAACTTTTTCCTAAA 2160 
                 ..... . .. ********.**** *******.     .... ..    .....  .    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 2220 
FMV-Can01        AGTTGTATACCTGCTGGATAGAGATGTATACTCTAATCCTTGATTTCTTTAAGCTTTTTT 2220 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNN 2248 
FMV-Can01        TGATTTTGTTATGTTAAGAGGAGAACAC 2248 





FMV RNA3-putative nucleocapsid protein gene 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 60 
FMV-Can01        AGTAGTGAACTCCCATAATTAACTCAAAATCAAACAGATCTAACATCATTTTTATATTGG 60 
                  .. ...   .    .  ..   .     .      . . .    .  ..... . .... 
      ?ORF3 start   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 120 
FMV-Can01        TATTTTACTCCAAAGTACTTTTTCTCATTAGAATATATCATGGCACCTAAGAGTAAGACT 120 
                 . ....  .     ..  ..... .  .. .  . . .  ...    .  . ..  .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 180 
FMV-Can01        ACATCAGCAAGCTCCAGCAAGATCACTCTTGGTCATATGCAAGAAAACACTATCTTACTG 180 
                    .  .   . .   .   . .   . .....  . ..   .       . . ..  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 240 
FMV-Can01        GGCTCAGGTTCGAAGCTTAAGGCTATTAAACTGACTAATGTGGTTAACGGTAAGTTAACT 240 
                 .. .  .... .  . ..  .. . ..    ..  .  .......   ...  ...   . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 300 
FMV-Can01        CATCCTGAGACATCTGACTTGAAACCTATAGATGTAGAAGTGCAAGCTTTTACCTCTGCA 300 
                   .  .. .   . ..  ...     . . . ... .  ...   . ....   . ..   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 360 
FMV-Can01        AGTCAGAATATCAGCAATTTCACACTTCACAAGTATCGTAACATATGTCATGTTGACACA 360 
                  ..  .  . .  .   ...     ..     .. . ..    . ...  .....      
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 420 
FMV-Can01        TGTGCTGCACATCTCTCTAAGTCTAAGGAGAATAAAGAGAAGCTTCAAGCCAGAAATTTG 420 
                 .... ..    . . . .  .. .  .. .  .   . .  . ..   .   .   .... 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 480 
FMV-Can01        AGATTGATCGTATCATCAAATGAATTTTTGGTGGTTGTTAAAGAGCTTAATGATAGTACA 480 
                  . ... . .. .  .    ..  ...............   . . ..  .. . ..    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNAAWAAAGCATGTGCTATYATGTCAGCTGGTATACTCAAA 540 
FMV-Can01        GTTGATAATGTTGTTTCTTTTAACAAAGCATGTGCTATCATGTCAGCTGGTATACTCAAA 540 
                 .... .  ........ ....** ************** ********************* 
 
FMV-Hel          CACACTTTCGACGAGGAATTTGACTGGAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 600 
FMV-Can01        CATACCTTTGATGAGGAATTTGACTGGAAATTATCAAAATATGTAAAGACGAACAATACT 600 
                 ** ** ** ** ***************** .. .     . ...   .  .     .  . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 660 
FMV-Can01        ACTAAGGTAGTTCCTGATGTGAAAATCATAAACAGACTAGCGGGTCAGATGGGCTTATCA 660 
                   .  ... ...  .. ....    .  .     .  . . ....  . .... .. .   
 
FMV-Hel          NNNNNNNNNNNNTATTACTGGATGATAGTACCTGGTTATGAATTCTTGTATGAACTGTAC 720 
FMV-Can01        GCTGGTAATCCATATTACTGGATGATTGTGCCTGGTTATGAATTCTTGTATGAACTGTAT 720 
                 . ....  .   **************:**.*****************************  
 
FMV-Hel          CCAGCTGAGGTATTAGCATACACTCTTGTGAGNNNNNNNNNNNNNNNNNNNNNNNNNNNN 780 
FMV-Can01        CCAGCTGAGGTATTAGCATACACTCTGGTAAGGCTCCAATACAGGAAAAACCTAAACATA 780 
                 ************************** **.**. .    .   ..       .     .  
 
FMV-Hel          NNNNNNNNNNNNACTGATGCTGACATTGTTAGTTCACTTGTTATGAAAATGAACAGGATT 840 
FMV-Can01        CCAGATAGTATGACTGATGCTGATATTGTCAGTTCTCTTGTTATGAAAATGAATAGAATT 840 
                    . . .. ..*********** ***** *****:***************** **.*** 
 
FMV-Hel          CATAAACTTGAANNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 900 
FMV-Can01        CATAAACTTGAACAGACCAGCTTTGATGAAGCCCTAAATCTTATAGGCAAGGATAACGTA 900 
                 ************  .    . .... ..  .   .   . .. . ..   .. .   ..  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAAAGAGGAAT 960 
FMV-Can01        TCTGAAGCTTATGTAGAACTTGCAAGAGATATAGGAAGCACGAGCAAGACAAAGAGAAAT 960 
                 . ..  . .. ... .   ...   . . . . ..  .   . .   .  ******.*** 
 
FMV-Hel          GATGAAGCTATTNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1020 
FMV-Can01        GATGAAGCAATTCTTAAGTTTAAGGAGTTAATTGCATCATTCCTACCTGCACTTGAAGCA 1020 
                 ********:*** ..  ....  .. ...  ...  .  ..  .   ..   ...  .   
     ?ORF3 end   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNTACTTTTTATTACTCTTTTCTNNNNNNNNNNNNN 1080 
FMV-Can01        GATAGGATTGCAAGTGCTCATGTTTGAACTTTTTATTAGTCTTTTCTGATGTTTGTATTA 1080 





FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1140 
FMV-Can01        GTTAAATAATAAATTTAATATAATTAATAGTATATCTTAGTATATATTAATGTAATCTAA 1140 
                 ...   .  .   ...  . .  ..  . .. . . .. .. . . ..  ...  . .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1200 
FMV-Can01        GTGTGTTATTAGCAATATATATCTATGTGTGTACTTGCTAAGAATACAAAATTAAAAAAA 1200 
                 ....... .. .   . . . . . .......  ... .  .  .      ..        
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1260 
FMV-Can01        CAAAAATATATAAGATGATGTAAGATGTGTAAGTGTGTATATATGTTCTTCAAGTTTCTT 1260 
                       . . .  . .. ...  . .....  ...... . . .... ..   .... .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAAAAA 1320 
FMV-Can01        AAATATCAACAGTGTTCAATATATGTATTGTGATCTATTATATGTTTATCATGAAAAAAA 1320 
                    . .     .....   . . ... ..... . . .. . ..... .  ..  ***** 
 
FMV-Hel          AMCAAAAAAAWSAAAAAAATCATAAAAAGACAAAAAAAAGAWATATATRTATATATATGT 1380 
FMV-Can01        ACCAAAAAAAGCAAAAAAATCACAAAAAGACAAAAAAAAGACATATATGTATATATATGT 1380 
                 * ******** .********** ****************** ****** *********** 
 
FMV-Hel          GNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1440 
FMV-Can01        CGAAACTCCGTCTTGAAAATCTATCTGACACGTATTTTTCTTTATTGATACCATTGTTAG 1440 
                  .    .  .. ...    . . . ..    .. ..... ... ... .    ..... . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1486 
FMV-Can01        ATTTGTTAAGATTTGACTGATTTAGTTTTAAATTATGGGAGAACAC 1486 





FMV RNA4-P4 gene 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 60 
FMV-Can01        AGTAGTGAACTCCTTACATCATAAACAAACTGATAGAAAAAATATTAAATCCTTAAAGTA 60 
                  .. ...   .  ..   .  .        .. . .      . ..   .  ..   ..  
             ?ORF4 start   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 120 
FMV-Can01        AGTTTAATTCACCTTAAAAGGATGTTTATTTCCTCGATTCTGCTGCTTGCTGTATGCATG 120 
                  ....  ..    ..    .. ..... ...  . . .. .. .. ... ... ..  .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 180 
FMV-Can01        TTCCCTAGTACTAGTGGAATGAAACCAACTGATGTGAACAATCATGAATTCACAAAAGAT 180 
                 ..   . ..  . ....  ..        .. ....     .  ..  ..       . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNTATTACTGAGATCACATGGAACAGTATAAAATCCATGAAC 240 
FMV-Can01        GGATTAAATAGTATCGAATCTATGACTGAGATTACATGGAACAGTATAAAATCCATGAAT 240 
                 .. ..   . .. . .  . *** ******** **************************  
 
FMV-Hel          ATNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 300 
FMV-Can01        GTCAAAGTCAGGCTTCCAGTTAAGGCTGAAACCTGTGAACTGCCAATCTCAGTGTACCAT 300 
                 .*    ..  .. ..   ...  .. ..     ....   ..    . .  ....    . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 360 
FMV-Can01        GATCTCTGGAAAAGATGGATGGCTACAAAACAAGCAATGACAAGGATAGCTAACGTAGCT 360 
                 . . . ...    . ... ... .         .   ..    .. . . .   .. . . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 420 
FMV-Can01        GTGCTTTGGACGCCAACTTCCAGTATGTTTATTGAAATGGCGACACTAATAGTCATTGAT 420 
                 ... .....  .     ..   .. ..... ...   ... .    .  . ..  ... . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 480 
FMV-Can01        GGCAGATTTAAGGATAGTGGTATCAAAGCTGGTAAGAAAGAGCTTTTGAAAACTGGCAAG 480 
                 ..  . ...  .. . ..... .    . ....  .   . . .....     ...   . 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNACAGCAGTCCCATTYGATCCAAATTTCCAA 540 
FMV-Can01        ATTAATGTTGATCTTGTTGGAAACACAATAACAGCGGTGCCATTTGATCCAAATTTCCAG 540 
                  ..  ..... . .......        . *****.** ***** **************. 
 
FMV-Hel          CAGTTNATAACTGGTTCACTTGACTTTGCTACTGAYACAATGGATATAAACAAGATTAAG 600 
FMV-Can01        CAATTTATAACTGGTTCGCTTGATTTTGCAACTGATACAATGGATATCAACAAGATCAGG 600 
                 **.**.***********.***** *****:***** ***********.******** *.* 
 
FMV-Hel          TTCTATATCTCATTTCCTGACACAAGAATGTCACAAACATNNNNNNNNNNNNNNNNNNNN 660 
FMV-Can01        TTCTATATTTCCTTTCCTGACACAAGAATGTCCCAAACAGATTCGACTGCTGGGTTTCTT 660 
                 ******** **.********************.******  .. .  .. ....... .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNTGATAATGGWKTMTMTGAAAAKGTTCAATGGGAT 720 
FMV-Can01        GATATATCATGGAAAACCTTGCCAGATGATAATGGAGTATATGAAAAGGTTCAGTGGGAT 720 
                 . . . .  ...      ...   . *********  * * ****** *****.****** 
 
FMV-Hel          GTGTTTACGTTTGATNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 780 
FMV-Can01        GTGTTTACTTTTGAAAAACAATTACCTGCTGAAGTAGCTCTAATGTCTGGAAGCAATAAC 780 
                 ******** *****:      ..   .. ..  .. . . .  ... ...  .   .    
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNGATAAAAAATACAAYGAAAGGAAAGAYGCNNNNNNN 840 
FMV-Can01        TTCCAGAAAATAAAGAGTTACTTGGACAAAAAATACAATGAGAGGAAAGATGCTCTTAGA 840 
                 ..   .    .   . ...  ...** *********** **.******** **. .. .  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 900 
FMV-Can01        CAGCTTGAAGACTTTTCCAATGCTTTAATCTGGGGCACTGATCAAGGGCTTAACAAGATG 900 
                   . ...  .  ....    .. ...  . .....   .. .   ... ..     . .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 960 
FMV-Can01        AAGAACAAACTTAATGAAGATACAAGTTCTTCAAACTTGCTTTTGAGGGATAGCACAAAA 960 
                   .       ..  ..  . .    ... ..     ... ..... ... . .        
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1020 
FMV-Can01        AGGGTTGAAGCCATTAAACTCAAACAAATCCAATCTGAGATGTCTGATGCCAAGAGCAAA 1020 
                  ......  .   ..    .        .    . .. . ... .. ..    . .     
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1080 
FMV-Can01        CTCACTGAAGCTTTAGCAGGCAATGACATTGCAATAATAGAATCTGCCAAAGCTGCATTG 1080 






FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1140 
FMV-Can01        GTAGCAGTATTCAACAAGTATAACATTCCATTACCAGTGTCTGAAAACACTGAGGAAGGA 1140 
                 .. .  .. ..      .. .    ..   ..    .... ..       .. ..  ..  
       ?ORF4 end   
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNTATTTTTTTGTTTTTTTCTCTTTNNNNNNNN 1200 
FMV-Can01        TATGTTATCATTGGTAATGCTCAGTAATCTATGTTTTTGTTTTTTTCTATTTTAAACTTA 1200 
                 . .... .  .....  .. .  ..  . *** ***************.***.    ..  
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1260 
FMV-Can01        TCTGTCTATTGCTGTGTTTTGTTTACCTATTTTATTGTAATGTTGTGTCTATCTATATAA 1260 
                 . ... . ... ............   . .... ....  ........ . . . . .   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNAA 1320 
FMV-Can01        ATTATGTACTTCTTTCACTTTGTTTAAATGTTTCAATTATGTTATCTTAGAAAATCCAAA 1320 
                  .. ...  .. ...   .......   .....   .. .... . .. .    .   ** 
 
FMV-Hel          AAAAAAAAAACCATAAAAAGYGGTTGCTTGCAAYCCNNNNNNNNNNNNNNNNNNNNNNNN 1380 
FMV-Can01        AAAAAAAAAAACCTAAAAAGAGGTTGCTTGCAACCCATCTAAGTCCGATATACTAAGGAA 1380 
                 **********.*.******* ************ ** . .  ..  . . .  .  ..   
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 1440 
FMV-Can01        CTCTGCAAGTTTTTAGGATGTTGATTACTTAACTTTTGATATTTTTCTTAGCTTTTGATT 1440 
                  . ..   ...... .. ..... ..  ..   ..... . ..... .. . ..... .. 
 
FMV-Hel          NNNNNNNNNNNNNNNNNNNNNNNNNN 1466 
FMV-Can01        GAACAATTTTGTTATGTAAGGAGAAC 1466 
                 .     ....... ...  .. .    
 
 
 
